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ABSTRACT
PROFILING TRANSCRIPTION AND RETROTRANSPOSITION OF MOUSE L1
SUBFAMILIES

LINGQI KONG
2020

Transposable elements, also called jumping genes, comprise almost 45% of the
human genome. In contrast, only 1% of the human genome is protein-coding sequences.
The function and advantages of maintaining such massive copies of transposable
elements in the human genome are still unclear. Long interspersed element 1 (L1), the
most substantial group and the only active autonomous transposable element in the
human genome, has revealed its unique roles in many diseases. The insertional
mutagenesis induced by L1 retrotransposition events could threaten human genomic
stability and generate unexpected mutations. L1 overexpression has been documented in
both somatic and germline cells and, most prominently, across different cancer samples.
A recent study in colorectal cancer samples by whole genome sequencing showed that L1
insertions could initiate tumorigenesis.
Because of the many challenges to studying the L1 pathological impact on the
human genome, an animal model is urgently needed. The high similarity between human
and mouse L1s motivates us to have a comprehensive understanding of endogenous
mouse L1 elements. A previous study estimated that over 3000 L1 elements are currently
active in the mouse genome. Both open reading frames and functional internal promoters
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are required for successful retrotransposition events. To capture and understand L1
activity in the mouse genome, we utilized bioinformatics expertise to create a potential
active L1 pool by filtering out any element not possessing intact ORFs or less than a 2monomer length promoter.
After cloning representative L1s directly from the mouse genome, we evaluated
those L1s with both promoter and retrotransposition activity by our dual-luciferase
reporter assay. In our study, we have demonstrated L1 elements transcriptional profiles
across different young subfamilies. With our high throughput assay, we compared
promoters’ expression across three different cell lines. Our study revealed that cellular
environmental factors could significantly influence L1 expression levels. Our research
also demonstrated that loci location, mutations, and incomplete monomer length are
critical for transcription. Moreover, our data suggest that high promoter activity is
essential, but not a determining factor for L1 retrotransposition activity. Our study
extended current knowledge in L1 biology and provided many potential future directions
for the study of L1.
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Chapter 1
Introduction

1. History of transposable elements
Ever since the pioneer investigation on chromosome breakage in the maize
genome initiated by Barbara McClintock, researchers have been aware that genome
instability can be triggered from an endogenous source (McClintock, 1950), namely,
transposable elements (TEs). TEs are responsible for interrupting a pigment gene and
altering the kernel color phenotype in maize. Moreover, her ensuing study revealed that
TE insertions could also manipulate adjacent genes' expression nearby (McClintock,
1956). Since then, scientists have started to realize that eukaryotic genomes are not
intrinsically stable entities. Any organism that is the host of TEs potentially can be
altered or disrupted in their genomic sequences. TEs are found in nearly all eukaryotic
species.
In the early years of TEs discovery, some people believed that they were the
ultimate parasite, comprising "selfish DNA" existing in genomes. Moreover, they
claimed that TEs were responsible for originating more copies of themselves and
spreading across the host genome. At the same time, most of the spreading process had
little effect on the phenotype for the host organism (Orgel & Crick, 1980). At the same
time, another group of researchers realized that when "selfish DNA" replicates within the
host genome, new copies could induce mutations or cause genetic diseases
(Charlesworth, Sniegowski, & Stephan, 1994). Is that all TEs can do? Besides neutral and
harmful effects, TEs also induce de novo insertions that could positively contribute to the
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host genome and potentially contribute to their hosts' evolution. For example, a recent
study generated a set of TE (P-element) insertion lines in Drosophila melanogaster, and
one line showed extended life-span and adaptive resistance to environment change (Lin,
Seroude, & Benzer, 1998). Since then, the concept that TEs have a significant impact on
both evolution and individuals’ genomic stability became the field's consensus.

2. Classification of transposable elements
Finnegan established the first TE classification system back in 1989. In his
proposal, there are two distinct classes. Class I is RNA mediated and also commonly
called 'copy-and-paste' TEs. Class II is comprised of DNA transposons, and are
commonly called 'cut-and-paste' TEs (Finnegan, 1989). In addition, there are target site
duplications (TSDs), which are short repeat sequences occurring on both sides of de novo
insertion sites. Due to its features, the length of TSD also can be helpful for TE
classification. Besides distinct replication strategies utilized by the two classes (Class I
and Class II), TEs encode a few unique proteins across different subfamilies, which can
also aid in TE classification. Clearly, the 'copy-paste' mechanism cored retrotransposons
have broad distribution and contribution for repetitive elements in genomes (Han &
Boeke, 2005).
Class I TEs fall into two major types, long terminal repeat (LTR) retrotransposons
and non-LTR retrotransposons. LTRs are repeating DNA sequences on both 5' and 3'
ends of LTR retrotransposons, and they have an extraordinary size range from a few base
pairs to 25 kb (Neumann, Pozarkova, & Macas, 2003). LTR retrotransposons
predominate in plants, but only account for a small portion of the human genome
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(Cordaux & Batzer, 2009). Depending on species and TE type, LTRs can be up to a few
thousand base pairs away from a TE's specific locus. Once integration occurs, LTR
retrotransposons produce a 4-6 bp TSD. Usually, TSD sequences are unique and can be
utilized as a fingerprint for each locus. Besides, LTR retrotransposons typically contain a
family-distinct ORF that includes a capsid protein (GAG), aspartic proteinase (PR),
reverse transcriptase (RT), RNase H(RH), and DDE integrase (INT).
Consequently, there are some functional similarities of ORFs between
retroviruses and LTR retrotransposons, which strongly indicates that they are
evolutionarily related. Within non-LTR retrotransposons, long interspersed element
(LINE) and short interspersed element (SINE) are two predominant families. LINEs lack
LTRs, and their length varies up to several kilobases. R2, L1, RTE, I, and Jockey are five
major families. Each family can be further subdivided into many subfamilies. An RT and
endonuclease are essential for autonomous LINEs' mobility. Unlike retroviruses utilizing
integrase, retrotransposons rely on endonucleases to nick the host genomic DNA and RTs
to generate complementary DNA from retrotransposon RNA templates via reverse
transcription. Besides LINEs, SINEs produce TSDs and usually are significantly shorter
in length, which could be up to a few hundred base pairs. SINEs hold an internal
promoter that drives transcription by RNA polymerase III (Pol III). Since SINEs are nonautonomous elements, they rely heavily on the functions of RT from LINEs
(Dewannieux, Esnault, & Heidmann, 2003; Kajikawa & Okada, 2002). As the most wellknown type of SINE elements, Alu has over one million copies in the human genome
(Lander et al., 2001; Rowold & Herrera, 2000). Alu is known for its selfishness of
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continuous replication in the host genome and its capability to cause human inherited
diseases and cancers (Hancks & Kazazian, 2016).
There are two significant subclasses of class II TEs, and they differ by way of the
transposition process, although they both follow the 'cut-paste mechanism'. Subclass I
elements have terminal inverted repeats (TIRs) and can acquire more copy numbers via
chromosome replication. At the beginning of the transposition process, a transposase is
required to reorganize the TIRs and cut both ends while relocating to another site of the
genome. Despite the similar 'cut-paste mechanism' of the two subclasses, subclass II
undergoes the transposition process differently. Subclass II elements only break one
strand to process single-stranded DNA migration.

3. 'Functions' of transposable elements
Ever since TEs were discovered in maize, scientists have been aware of their
capability of disrupting gene expression. Scientists have observed TEs participating in
genome restructuring and their ability to induce chromosomal mutations. In 1987,
McClintock noted that TEs are one of the critical participants to restructure the genome in
response to stress (McClintock, 1978). More recently, a set of comprehensive studies
have well demonstrated that TEs can directly alter neighboring genes' expression in both
transcriptional and post-transcriptional processes (Britten, 1996; Brosius, 2003; MarinoRamirez, Lewis, Landsman, & Jordan, 2005). The best known mechanism for TEs to
directly impact the host genome is to induce an insertion in the exons of genes. Most
often, it disrupts the gene's function and causes a frameshift mutation. Even if the
insertion happens in non-coding sequences, TEs could generate a broad spectrum of
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possible consequences. For example, almost 25% of human promoters contain TEderived sequences (Jordan, Rogozin, Glazko, & Koonin, 2003). At the same time, those
genomic variations would contribute to a positive evolutionary process. It has been
shown that accumulating single DNA base pair mutations is sufficient for diversity and
optimization of protein-coding sequences (Maeshiro & Kimura, 1998). TEs can generate
rapid genomic revision and elevate the pace of creating protein diversity (Bogarad &
Deem, 1999). A comparative genome study identified two highly conserved TE
subfamilies (MIR and L2) at orthologous intergenic regions in both human and mouse
genomes (Silva, Shabalina, Harris, Spouge, & Kondrashovi, 2003). The authors
hypothesized a selection pressure to preserve these ancient TEs since the ancient
divergence of humans and mice (Silva et al., 2003). Indeed, both MIR and L1 sequences
not only are enriched for enhancer-like repeats (ELRs) and promoter-like repeats (PLRs)
but also interact with each other extensively in the 3D genome (Cao et al., 2019). Besides
influencing the host gene expression profile and being conserved across different species,
more and more evidence confirms that TEs have a unique role in evolutionary and
biological diversity.
Moreover, a recent study revealed that endogenous retroviruses (ERV), class I TE
elements, have a substantial number of P53 binding sites in their LTRs (T. Wang et al.,
2007). ERVs are primate-specific TEs and compromise 8% of the human genome
(Lander et al., 2001). P53, a tumor suppressor gene, and critical transcription factor plays
a significant role in the transcriptional regulation network. This evidence shows TEs
could be an essential factor to help form a transcriptional network for p53. Interestingly,
p53 protein is also a critical gatekeeper in the genome to prevent DNA damage and
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maintain the genome's stability, while TE elements are always trying to expand their
territories. Another recent study has even more precisely unveiled how TE families can
be involved with genome-wide transcriptional regulation in trypanosomatids (Bringaud et
al., 2007). Those TEs’ non-coding RNAs can play critical cellular functions in
destabilizing the coding genes' mRNA. Experiments have confirmed LmSIDER2 (an
extinct family of retrotransposons in trypanosomatids) in the 3'UTR (untranslated region)
of the target gene significantly reduces the target gene's expression level.
It is evident that small RNAs (smRNAs) play an essential regulatory role in gene
expression via RNA interference (RNAi). MicroRNAs (miRNAs), small interfering
RNAs (siRNAs) and PIWI-interacting RNAs (piRNAs) are the most well-known
regulatory RNAs in the class. Typically, they act either through mRNAs' destabilization
or suppressing the translation process by base-pairing with complementary sequences of
mRNAs. Since discovering different small regulatory RNAs, more and more studies have
revealed the unique relationship between smRNAs and TEs. Specifically, the endogenous
RNAi system in mouse acts to silence TE activity depending on specific tissues and
developmental timings (Sijen & Plasterk, 2003). A follow-up study further confirmed
that TEs are significant targets and resources of siRNAs (Watanabe et al., 2006).
Coincidently, the Kazazian group found that cultured human cells could generate
siRNAs, and antisense promoter activity from L1s is critical for fabricating those siRNAs
(Yang & Kazazian, 2006). Although much evidence exists that the TEs are not 'junk
genes', further studies are needed to better understand these repeat elements.

4. DNA transposons in the human genome
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Similar to other mammal species, human TEs can be generally divided into two
major classes based on their intermediate transposition mechanisms. Class I TEs are
referred to as retrotransposons and use a 'copy-and-paste' mechanism, while class II TEs
are DNA transposons and utilize the 'cut-and-paste' mechanism. Except in bats, class II
TEs or DNA transposons are currently inactive in the context of transposition ability
(Mitra et al., 2013; Ray et al., 2008). However, there is evidence that some DNA
transposons have novel functions. A salient example is recombination-activating genes
(RAGs), which encode RAG1 and RAG2 proteins (collectively called RAG). Like cutand-paste DNA transposases, RAG can recognize, cleave, rearrange, and recombine
DNA sequences to form different immunoglobulins' variants with the same DNA
template in the immune system (Fugmann, 2010; Lewis, 1994; Ramsden, Baetz, & Wu,
1994). Besides RAG, the THAP9 gene and PiggyBac-like TEs are two other examples of
DNA transposons’ footprint in the human genome, and both still encode active DNA
transposases (Bailey et al., 2012; Majumdar, Singh, & Rio, 2013; Pavelitz, Gray, Padilla,
Bailey, & Weiner, 2013). When the human genome sequencing project finished in 2001,
some human genes were found to share a highly conserved region and could be derived
from DNA transposons (Lander et al., 2001).

5. LTR retrotransposons in human genome
Human retrotransposons can be subdivided into LTR and non-LTR types. Human
LTR retrotransposons are also referred to as human endogenous retroviruses (HERVs),
which account for about 8% of the human genome (Lander et al., 2001). The HERVs are
DNA sequences originally acquired from retroviral infection and integration into the
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germline, and have been part of the human genome for 100 million years (primates
having emerged ~60 million years ago) (Vargiu et al., 2016). Those ancestral retroviruses
began with somatic cells' infection via viral membrane fusion and entry into host somatic
cells. Once in the cytoplasm, the RNA template of a retrovirus is reverse transcribed into
a DNA fragment by the reverse transcriptase. Unlike retrotransposons, viral integration in
the host genome is mediated by the viral integrase. Hence, HERVs share a similar overall
structure of a typical retrovirus, including two flanking LTRs, and viral coding gene Gag
and Pol. However, the defensive system in the host genome and neutral mutations in
those proviral DNA sequences lead to defective viral coding proteins or even non-coding
RNAs. Most HERVs lack fully functional protein-coding genes and have LTR on only
one side of the element, which leads to their inactivity. Although there is currently a lack
of comprehensive study to compare locus-specific activity across HERV loci, it has been
well demonstrated that HERVs have broad expression profiles across different human
tissues from healthy individuals and cell lines, and are associated with diseases including
cancer (Blond et al., 2000; Grandi & Tramontano, 2018; Mi et al., 2000; Flockerzi et al.,
2007; Haase, Mosch, & Frishman, 2015; Stauffer, Theiler, Sperisen, Lebedev, &
Jongeneel, 2004). One specific subfamily called HERV-W (~1% of the human genome)
can potentially be mobilized by L1-mediated retrotransposition (Pavlicek, Paces, Elleder,
& Hejnar, 2002). By utilizing both reverse transcriptase and endonuclease encoded by L1
sequences, HERV-W can potentially generate de novo insertions and have a pathogenetic
impact on human health. Still, more evidence is needed to confirm that HERV-W causes
diseases. Another exceptional case is HERV-K. With the help of the 1000 Genomes
Project, scientists have newly identified intact insertions and solo-LTR copies in
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sequencing data (Wildschutte et al., 2016). However, the current consensus is that
HERVs are transpositionally inactive in the human genome.

6. Non-LTR retrotransposons in human genome
Non-LTR retrotransposons account for 33.7% of the human genome, which is
three times more than LTR retrotransposons or about twelve times more than DNA
transposons (Cordaux & Batzer, 2009). L1, Alu, and SVA elements are the major
components in the category. Additionally, other non-LTR retrotransposons only account
for a small fraction of the human genome (Cordaux & Batzer, 2009). Those other nonLTR retrotransposons are ancestral elements and can be used as genomic fossils to study
TE elements' evolutionary history in the human genome (Kamal, Xie, & Lander, 2006).
As the most abundant TEs in the human genome, Alu comprises over one million
copies and accounts for almost 11% of the genome size (Lander et al., 2001). On average,
Alu has around 300 bp length and replicates via an RNA mediated 'copy-and-paste'
mechanism. In fact, Alu belongs to non-autonomous TEs and requires trans-acting
assistance from L1. Their parasitic expansion relies on L1, which is the only active
autonomous human TE family (Dewannieux et al., 2003). More specifically, open
reading frame 2 (ORF2) from the L1 element nicks the host genome and replicates Alu
via target-primed reverse transcription (TPRT). Based on the Dewannieux study, ORF2 is
sufficient for the mobility of Alu. Further study revealed that L1 open reading frame 1
(ORF1) could enhance Alu retrotransposition (Wallace, Wagstaff, Deininger, & RoyEngel, 2008). Besides insertional mutagenesis, non-allelic homologous recombination
between Alu repeats can also be pathological. Substantial Alu distribution in the human
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genome also can influence local gene expression, for example, by forming
polyadenylation signals and truncating transcripts (Chen, Ara, & Gautheret, 2009).
Although Alu has detectable level transcripts expressed by its internal RNA polymerase
III promoter (Paolella, Lucero, Murphy, & Baralle, 1983), the majority of Alu copies are
inactive in the genome due to DNA methylation or chromatin modification (Englander,
Wolffe, & Howard, 1993; Liu & Schmid, 1993; Slagel & Deininger, 1989). Still, Alu
plays an important role in human diseases, including familiar genetic diseases, various
cancers, and neuron diseases (Hancks & Kazazian, 2016).
SINE-VNTR-Alu (SVA) elements are the evolutionarily youngest human
retrotransposons remaining active in the genome. SVA has a chimeric structure, and the
total length for SVA is around 2kb (Wang et al., 2005). From the 5'end, SVA starts with
'CCC TCT' hexamer (up to nearly a hundred copies), an Alu-like domain (antisense Aludomain fragments), GC-rich variable number tandem repeats (VNTR), a SINE-R
domain-containing env sequences and a HERV-K 3' LTR, and ends with a 3'end poly A
tail (Damert, 2015; Hancks & Kazazian, 2010, 2016). Based on the 3'end poly A signal
sequence (AATAAA) fingerprint, SVA is predicted to be transcribed by RNA
polymerase II.
Long interspersed element-1 (LINE-1 or L1) is a major non-LTR
retrotransposon in the human genome. There are over 500,000 L1 copies in the reference
genome (Lander et al., 2001). Although a large portion of L1s are inactive due to genome
rearrangement, accumulative point mutations, and 5'-truncation, recent studies revealed
that each individual human genome has roughly 80~100 active L1 retrotransposons that
potentially could induce de novo insertional mutagenesis (Brouha et al., 2003). The 1000
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human genome project has already shown that some hyperactive L1 elements are only
present within a specific race or ethnic group (E. C. Scott et al., 2016). This distribution
might explain why each ethnic group differs in colorectal cancer or other disease
incidence profiles. However, more comprehensive and detailed genomic sequence
collection is required to make that conclusion. An active full-length L1 element is usually
~6kb in length and has two open reading frames that are flanked by 5'UTR and 3' UTR
(Dombroski, Mathias, Nanthakumar, Scott, & Kazazian, 1991). The 5'UTR contains an
internal promoter, which is known as an important regulatory component in L1
retrotransposition. Although a study has shown that L1's promoter might be dependent on
RNA polymerase III (Pol III) (Kurose, Hata, Hattori, & Sakaki, 1995), a 6 kb L1
transcript was initiated by Pol III. Later study corrected this information, and revealed
that L1-related transcripts were transcribed by Pol II instead of Pol III (Yang & Kazazian,
2006).

7. L1 structure and its life cycle
L1 comprises around 17% of the human genome. Currently, L1s are the only
group of TEs that can independently and autonomously induce de novo insertional
mutagenesis in the human genome. In addition to its ability to generate new L1
insertions, L1 proteins can copy and paste Alu and increase Alu’s copy number in the
host genome. Undoubtedly, the biology of L1 elements in the human genome has become
essential to understanding the regulation of TEs in the genome and their de novo
insertional mutagenesis impact in vivo.
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8. 5'UTR of L1
The 5'UTR of L1, which is an internal promoter around 900 bp in length, is a
TATA-less promoter that can solely initiate transcription by recruiting RNA polymerase
II (Athanikar, Badge, & Moran, 2004; Swergold, 1990). Swergold first characterized
human L1 promoters with in vitro assays (Swergold, 1990). This study clearly showed
that human L1 transcription starts from the 5' end, and the first 100 bp are critical for
human L1 promoter activity. At the same time, the first 668 bases contribute significantly
to the overall expression level. In addition to 5'UTR's sense promoter activity, the human
L1 promoter can generate antisense transcripts, including those of adjacent cellular genes
(Speek, 2001). However, the precise biological function behind this is still unknown, and
it might be related to regulating expression of host genes (Thornburg, Gotea, &
Makalowski, 2006).
To further understand the regulation of L1 on the transcriptional level, a few
studies have demonstrated that some critical transcription factors (TFs) can influence L1
promoter activity. The first TF for human L1 promoter was discovered as an extension of
Swergold's work (i.e., the first 100 bp of human L1 5'UTR is critical for L1 expression).
A cis-regulatory factor binding motif was narrowed down to between base +13 and +21,
and the corresponding TF was identified as a ubiquitous transcription factor Yin Yang 1
(YY1) (Becker, Swergold, Ozato, & Thayer, 1993). Later it was revealed that mutations
within YY1 binding sequences have limited influence on L1 mobility but more on the
level of full-length transcripts. So YY1 is predicted to be part of the core promoter that
works with other basal transcription factors to initiate transcription, rather than solely
altering the level of transcription (Athanikar et al., 2004). Overall, YY1 has a substantial
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impact on the embryogenesis process, cell differentiation, and DNA replication. To be
more specific, YY1 can involve transcriptional activation and DNA strain conformation
altering, which are highly aligned with epigenetic regulation events (Gordon, Akopyan,
Garban, & Bonavida, 2006). Even though L1s are broadly distributed across the human
genome, their expression level can still be tightly regulated by the YY1 transcription
factor.
p53 binds within the L1 promoter sequences, and the binding site is broadly
distributed across L1 promoter sequences (Harris et al., 2009; Wylie et al., 2016). p53 is a
tumor suppressor gene responsible for preventing any unexpected change in the host
genome (Lane, 1992). p53 would limit the production of RNA transcripts from L1
elements, which is consistent with the p53 assigned function initially (to prevent cells
from rapidly dividing). Furthermore, another in vivo study with Drosophila has shown
that p53 expression can restrain transposon expression. A similar pattern was observed in
zebrafish and humans. Once p53 mutated, there was a dramatic increase in
retrotransposon activity in their assays, which indicated that p53 has a negatively
regulatory role in L1 activity(Wylie et al., 2016).
Interestingly, both YY1 and p53 are tightly involved in transcriptional regulation.
Their colocalization inside nucleoli with in vitro experiments showed that YY1 could
potentially decrease the binding affinity of p53 to its binding motifs (Yakovleva et al.,
2004). Since both p53 and YY1 participate in DNA damage and cell apoptosis, further
studies are required to understand better if there is any association between L1 promoter
TFs (YY1/p53) and L1 hyperactive expression profiles in tumor tissues.
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Members of the SOX family of transcription factors are involved in
transcriptional regulation of L1. Bioinformatic analysis predicted two potential SOX
binding sites in the L1 promoter. Over-expressing SOX11 enhanced L1 promoter activity
in a luciferase reporter assay (Tchenio, Casella, & Heidmann, 2000). Like the L1
expression pattern in neurons and embryogenesis, SOX11 has a partial overlap
expression profile in neurons. SOX11 expression in neurons is also described as critical
for neuron survival (Jankowski, Cornuet, McIlwrath, Koerber, & Albers, 2006). A recent
study has shown that SOX11 knock-down would reduce L1 activity, while SOX11 has a
higher affinity to bind L1 promoters in differentiating neuroblastoma cells. All evidence
has shown that SOX11 might support L1 retrotransposition activity during neuronal stem
cell differentiation (Orqueda, Gatti, Ogara, & Falzone, 2018).
Run-domain transcription factor 3 (RUNX3) is a heterodimer complex with two
different subunits and can recognize the core motif (5'-PYGPYGGT-3'). RUNX3 motifs
can be found in various enhancers and promoters across the genome. RUNX3
transcription factor has significant roles in epithelial cell growth and neurons'
development (Levanon et al., 2002; Q. L. Li et al., 2002). A recent study identified a
RUNX site in +83 ~ +101 of the human L1 (L1Hs) promoter, and its dysfunction would
reduce both transcriptional activity and mobility of L1 (Yang, Zhang, Zhang, &
Kazazian, 2003). Their results also indicated that RUNX3 potentially influences both the
sense and antisense of the L1 promoter transcription level.
Besides TFs manipulating L1 promoter expression in the human genome, CpG
methylation has been well studied and also shown to play a critical role in the
endogenous L1 suppression mechanism. Following Thayer and colleagues' finding that
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the methylation state correlates with human L1 expression, a more detailed study in 1997
showed that the first seven methylation sites (CpG islands) could significantly influence
promoter activity, and four of the seven within the first 100 bp 5'UTR region are
necessary for L1 promoter suppression (Hata & Sakaki, 1997; Thayer, Singer, &
Fanning, 1993). This discovery again confirmed that the first 100 bp are core region for
transcriptional activity of the human L1 promoter, and provided a potential mechanism
for substantial L1 suppression across somatic tissues (Leibold et al., 1990).
For environmental factors, McClintock hypothesized that naturally occurring
‘genomic shocks' could induce more activity of TEs. Recent studies have also shown that
environmental stress induces TE mobilization in plants (Kalendar, Tanskanen, Immonen,
Nevo, & Schulman, 2000). Moreover, steroid and heat shock (environmental stress) has a
regulatory role affecting retrotransposons in Drosophila tissue culture experiments
(Ziarczyk & Best-Belpomme, 1991). For human L1 retrotransposons, a recent study also
revealed that L1 retrotransposition activity could be manipulated with testosterone and
dihydrotestosterone interference in vitro assay (Morales, Snow, & Murnane, 2002).

9. ORFs of L1
Since a typical functional L1 element is around 6 kb in length, two open reading
frames can encode two proteins (ORF1p and ORF2p). Both are critical for L1
retrotransposition activity (Moran et al., 1996). The two ORFs are separated by a 63 bp
spacer. A recent study also showed a novel protein, ORF0p, can be encoded by the
antisense strand of 5'UTR and could benefit L1 retrotransposition activity (Denli et al.,
2015).
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ORF1, a ~40 kDa protein, has RNA binding and nucleic acid chaperone activity.
Both features of ORF1 are important for activating L1 retrotransposition activity(Martin,
Branciforte, Keller, & Bain, 2003; Martin & Bushman, 2001; Martin, Li, & Weisz,
2000). Previous studies have demonstrated that ORF1 is more likely to assist in the
structural aspect than specific enzymatic functions (Martin, 1991; Martin & Bushman,
2001). ORFs were initially described for the mouse L1 element L1Md-A2 back in 1986,
revealing two overlapping open reading frames and a unique monomer structure in the
5'UTR region of that mouse element (Loeb et al., 1986). They proposed that the 3' half of
the ORF1 is subject to specific selection during the evolutionary process due its high
similarity with primate L1 sequences. Also, in the early study, they found the ORF1
amino acid sequences are lysine rich. Lysine is a basic amino acid and is capable of
binding nucleotides (DNA/RNA). Further study has revealed that ORF1p can bind to
ORF2 coding sequences and regulate ORF2 expression levels (Hohjoh & Singer, 1997;
Kolosha & Martin, 1997).
It seems that ORF1p has critical regulating roles of ORF2p expression via binding
on the second ORF RNA transcripts in early retrotransposition events, and assisting RNA
transfer for the reverse transcription process in the later stage of ribonucleoproteins
(RNPs) formation. The unique structure of ORF1p was observed to favor L1
retrotransposition activity. The trimeric structure formed by aggregation of the ORF1p
coiled-coil domain is required for L1 retrotransposition (Martin et al., 2003). The central
domain of ORF1p called an RNA recognition motif (RRM) can interact with the Cterminal domain and recognize defined sequences. Any introduced mutations in either
domain could dramatically reduce the ORF1p binding affinity of RNAs and L1 RNP
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formation (Khazina et al., 2011). Either mutation will affect the L1 retrotransposition
activity downstream.
In in vitro assays, the chaperone activity of ORF1p is heavily involved in
mediating nucleic acid strand transfer at the beginning of the reverse transcription process
(Martin & Bushman, 2001). It can help anneal with the complementary DNA strand,
stabilize RNA when hybrids form, and selectively retain a stabilized complex (dissociate
an imperfect complex). In most cases, ORF1p favors mobilizing its mRNA template in
cis to increase donor L1 copies in the genome. However, intact ORF1p can also promote
mobility of mutant L1s in trans (Wei et al., 2001). The trans-acting function of ORF1p
could also be an essential player to form massive copies of pseudogenes (Esnault,
Maestre, & Heidmann, 2000).
ORF2, the second open reading frame of L1, encodes a 150-kDa polyprotein
ORF2p. ORF2p has multiple functions, including endonuclease (EN) and reverse
transcriptase (RT) (Feng, Moran, Kazazian, & Boeke, 1996; Mathias, Scott, Kazazian,
Boeke, & Gabriel, 1991). Engineered mutations at conserved amino acid positions in the
EN domain terminate its enzymatic activity and cause loss of retrotransposition activity
(Feng et al., 1996). Besides, the EN domain prefers to bind AT-rich sequences and nick
between A/T nucleotides (Cost & Boeke, 1998; Jurka, 1997). Also, the dynamic
epigenetic factor could have an impact on EN nicking efficiency. When DNA is
packaged into nucleosomes, it generally would be refractory to L1 EN cleavage on
potential nicking sites (Cost, Golding, Schlissel, & Boeke, 2001). Other studies revealed
that the EN domain shares a conserved region with Exonuclease III from E. coli (Mol,
Kuo, Thayer, Cunningham, & Tainer, 1995).
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The RT domain of ORF2p is located downstream of the EN domain (Feng et al.,
1996). RT domain is conserved across all non-LTR retrotransposons and was likely
acquired from a common ancestral source (Malik, Burke, & Eickbush, 1999). RTs in
non-LTR retrotransposons mostly function in the nucleus and convert RNA templates
into cDNA sequences at the target site, a process termed target primed reverse
transcription (TPRT) (Luan, Korman, Jakubczak, & Eickbush, 1993). However, RT in
the ORF2 domain is significantly different from retroviral RTs, which usually possess an
RNase H activity. During the L1 retrotransposition process, ORF2p is colocalized with
L1 transcripts and ORF1p. The colocalization indicates the formation of RNPs in the
cytoplasm. At the same time, it is evident that ORF2p has the capability of binding RNA
(L1 transcripts) and DNA (endonuclease nicking single-strain genomic DNA) (Doucet et
al., 2010).
Besides RT and EN domains, there is a third cysteine-rich domain of ORF2p that
is at the far end of the C-terminus (Fanning & Singer, 1987). This domain was found to
be important for L1 mobility (Fanning & Singer, 1987). Also, it initially was
hypothesized to be a zinc knuckle structure, which also occurs in other proteins having
the capability of binding of single-stranded RNAs (Barabino, Hubner, Jenny, MinvielleSebastia, & Keller, 1997). This hypothesis is further supported by a recent study showing
that the C-domain binds to RNA in a non-sequence-specific manner (Piskareva, Ernst,
Higgins, & Schmatchenko, 2013). Interestingly, as confirmed by mutagenesis studies of
the zinc knuckle structure, the cysteine-rich domain in other retroviruses has a critical
role in increasing nucleic acid binding affinity (Gorelick, Fu, et al., 1999; Gorelick,
Gagliardi, et al., 1999).
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ORF0, a primate-specific open reading frame, is located in the 5'UTR region and
encoded by an antisense transcript (Denli et al., 2015). Due to the presence of two
functional splicing donor sites in the antisense 5'UTR RNA and splicing acceptors
downstream, it also can form a fusion protein. Over-expressing ORF0 modestly increases
L1 retrotransposition activity (Denli et al., 2015). Genome-wide analysis indicates that
human L1 promoter antisense expression affects 4% of human genes, potentially forming
fused transcripts (Criscione et al., 2016). It remains unclear how ORF0 fused protein
could impact L1, as well as neighboring genes.

10. 3'UTR of L1
Downstream of the stop codon of ORF2, typical L1 elements incorporate a 200 bp
3'UTR ending with a polyadenylation signal (AATAAA) and a poly A tail. It is worth
noting that many times, the polyadenylation signal of 3'UTR is not strong enough, and
the L1 transcript could contain downstream flanking sequences (Moran et al., 1996).
Although the 3' end tail participates in ORF2p recruiting and regulates de novo insertion
events in LINE elements of plants (Schneider & Stephens, 1990), the 3'UTR of
mammalian L1s has no significant influence on retrotransposon activity (Moran et al.,
1996). In a pioneering study, heavily guanine-rich 3'UTR sequences were shown to form
an intrastrand tetraplex secondary structure in vitro (Howell & Usdin, 1997). A recent
study applied both computational and experimental designs and has demonstrated that
3'UTR does not have a stable and canonical secondary structure, but can form Gquadruplex (G4) structures (Sahakyan, Murat, Mayer, & Balasubramanian, 2017). G4 is
enriched in young L1 elements, and functionally promotes retrotransposition activity
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(Sahakyan et al., 2017). However, the previous in vitro study also showed that 3'UTR
deleted L1 elements could generate as many de novo insertions as wild-type versions.
That also indicates the 3'UTR of human L1 may not be critical for L1 retrotransposition
activity (Moran, DeBerardinis, & Kazazian, 1999).

11. Mechanism of L1 retrotransposition
As previously discussed, most L1 copies in the mammalian genome are inactive
due to 5' truncation, recombination, and accumulated mutations. Although L1s contribute
to 17% and 19% genomic volume in the human and mouse, respectively, full-length L1
elements make up only a small fraction of the many L1 copies in the genome (Lander et
al., 2001; Mouse Genome Sequencing et al., 2002).
For full-length L1s, their internal promoters in the 5'UTR region can initiate L1
transcription predominantly by RNA polymerase II (Moran et al., 1996; Naas et al., 1998;
Yang & Kazazian, 2006). It is worth noting that L1 encoding proteins are also larger than
typical RNA polymerase III transcripts. Although L1s have TATA-less promoters, the
mechanism of the L1 promoter is still not clear. In general cases, with the help of
multiple transcription factors and the complex formed along with TATA-less promoter
sequences, RNA polymerase II is recruited within initiator elements and starts to
transcribe through the sequences (Weis & Reinberg, 1997). It has been revealed that a
few transcription factors (in 5'UTR of L1 section) can manipulate and regulate L1
transcriptional expression levels. It still remains unclear how specifically the L1 promoter
works.
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L1 mRNA can be translated into two major open reading frames. Both proteins
have cis-preference and prefer to bind with their own mRNAs (Wei et al., 2001). Two
ORFs in human L1 are in the same frame but separated by a spacer, which is 63 bp in
length with multiple stop codons. In contrast, mouse L1 has two independent open
reading frames. It is worth noting that the translation mechanism for both ORFs is not
completely understood. In general, ORF1p, ORF2p, and L1 mRNA can form a complex
in a ribonucleoprotein particle (RNP), which is a critical step for mediating
retrotransposition activity (Doucet et al., 2010; Hohjoh & Singer, 1997; Martin, 1991).
The poly A tract downstream to 3'UTR is important for L1 retrotransposition activity via
RNP formation (Doucet, Wilusz, Miyoshi, Liu, & Moran, 2015). Another recent study
also noted the exciting possibility that post-translational modification could be associated
with the promoter, and further impact on retrotransposition (Rangasamy, 2013).
Since the ORFs and L1 RNA complex must gain entry into the nucleus from the
cytoplasm for the integration process, the exceptionally large size complex may require
nuclear envelope breakdown during mitosis or meiosis for nucleus entry. The integration
process after a complex enters the nucleus is called target primed reverse transcription
(TPRT). TPRT starts with the endonuclease domain from L1 ORF2p cleaving the minusstrand genomic DNA, and the nick will serve as a primer (Feng et al., 1996). The ORF2p
RT domain uses L1 RNA for reverse-transcription to fabricate DNA afterward, and the
whole process ends with complementary DNA sequences being inserted into the host
genome (Cost, Feng, Jacquier, & Boeke, 2002; Kulpa & Moran, 2006).

12. L1 associated with human diseases
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Unsurprisingly, L1-induced insertional mutagenesis can cause diseases by
disrupting functional genes, and over one hundred individual cases have been reported to
date (Hancks & Kazazian, 2016). There are potentially a few different approaches
whereby L1 can disrupt specific genes and lead to disease development. The
straightforward way is when L1 insertion happens in exons and disrupts the sequences. It
could also insert into introns and shift the original splicing frame, disabling RNA
transcripts. Even if L1 insertions happen in a non-critical genome location, it is still
possible that L1 can alter neighbor gene expression levels by its antisense promoter
activity and other epigenetic changes to the host genome.
Over three decades ago, the first de novo L1 pathological insertion was found in a
Hemophilia A patient (Kazazian et al., 1988). Recent studies have revealed that L1
insertional mutagenesis can be found in both tumor suppressor genes and protooncogenes (Bratthauer, Cardiff, & Fanning, 1994; Miki et al., 1992; E. C. Scott et al.,
2016). It is also evident that L1 can evade somatic suppression mechanisms and become
hyperactive in tumor tissues due to hypomethylated promoter (Estecio et al., 2007; Florl
et al., 2004; Sunami, de Maat, Vu, Turner, & Hoon, 2011). A broader tumor tissue
screening has also revealed a high insertion rate of L1 in tumor samples (RodriguezMartin et al., 2020). Ultimately, it is still unclear how L1 evades suppression, how often
L1 is involved in the pathogenesis process, and what its role in diseases is (driver or
passenger).

13. L1 associated with mouse diseases
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Similarly, L1s in the mouse genome can induce insertional mutagenesis, and L1
insertions comprise up to 3% of mutations in the genome (Ostertag & Kazazian, 2001).
There are five disorders in mice that have been reported previously, including L1
insertion in glycine receptor, reelin, Scn8a, neige and Mitf genes (Kingsmore et al., 1994;
Kohrman, Harris, & Meisler, 1996; Perou, Pryor, Naas, & Kaplan, 1997; Takahara et al.,
1996; Yajima et al., 1999). Three of them have been further investigated since they are
full-length L1 insertions (L1spa, L1orl, and L1bw). It is worth noting that all three elements
belong to one specific subfamily called TF subfamily, while other subfamilies should be
potentially active as well. An early in vitro study found that A-type promoter has many
more transcripts (approximately ten fold more) than F type in F9 cells and other mouse
cell lines (Schichman, Severynse, Edgell, & Hutchison, 1992). Recently reported
germline L1 insertions also belong to the TF subfamily (Richardson et al., 2017). Due to a
lack of comprehensive understanding of the actual activity of mouse L1s across different
subfamilies, it is still unclear why the TF subfamily shows the exceptional capability of
generating de novo insertion in vivo.

14. L1 biology study with mouse models
Since L1 insertional mutagenesis potentially could be a pathological driver in the
human genome, it is of interest to determine the influence of L1 in promoting
pathogenesis. To study L1 insertional mutagenesis in vivo, Ostertag and colleagues
reported the first human L1 transgenic mouse model back in 2002 (Ostertag et al., 2002).
Interestingly, the active human L1 element was not actively conducting transposition in
the mouse model, and only generated a limited number of insertions. Due to the lack of
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massive insertion events captured, a later study used a more active human L1 element
(L1-mless) as a transgene to generate another human L1 mouse model that yielded over
30 de novo somatic insertions (Babushok, Ostertag, Courtney, Choi, & Kazazian, 2006).
A later transgenic model study revealed that abundant L1 transcripts could be captured
from both male and female germ cells. Those L1 RNA transcripts can integrate into
offspring during early embryogenesis (Kano et al., 2009). It is worth noting that the
human L1 transgene in the mouse model has limited insertion events. Besides, several
host mechanisms regulating L1 activity during embryogenesis and gametogenesis have
been revealed (Bourc'his & Bestor, 2004; Newkirk et al., 2017; Wissing, Montano,
Garcia-Perez, Moran, & Greene, 2011). There is a potential caveat for using the human
L1 as the transgene in a mouse model if human L1 elements do not share the same
regulation patterns with mouse L1s. The previous study captured limited insertion events
in the human L1 transgenic mouse model. Moreover, A_I, the youngest mouse L1
subfamily, has never been observed to have retrotransposition activity in vivo (Sookdeo,
Hepp, McClure, & Boissinot, 2013). To fully capture the host regulatory mechanism in
vivo and understand the evolution of L1, profiling L1 activity across different subfamilies
is critical. The most active endogenous L1 also can be used as a transgene to generate a
mouse model for L1 biology study.

15. L1 subfamilies in the mouse genome
L1 expansion in the host genome would be a rich source of diversity in evolution
and natural selection, but the hyperactive L1 expression in the human genome would also
be a significant factor in host fitness (Boissinot, Davis, Entezam, Petrov, & Furano,
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2006). Both human and mouse L1s share a highly similar structure at the sequence level,
as well as evolutionary pattern, which follows single lineage evolution (Adey et al., 1994;
Khan, Smit, & Boissinot, 2006). It is still unknown why L1s usually follow a single
dominant lineage pattern. Interestingly, many different mammal species, including mice,
have shown a similar pattern where one subfamily merges at one moment and rapidly
expands its territory. The merged family starts to become extinct, and another new family
emerges in the host genome. However, the mechanism behind it remains unclear. Indeed,
the similarity between human and mouse is advantageous for L1 biology study, including
the components that can significantly influence L1 activity and all possible consequences
of L1 insertions in vivo. The current mouse genome has a dominant lineage in the Tf
subfamily along with several other potentially active subfamilies. So, the mouse could be
utilized as in vivo model to understand the evolutionary profile more comprehensively.
Recent studies have described a few active mouse L1 elements and all of them
come from either A or F types, with no evidence for the ancestral V type (the third type)
still remaining active nowadays (Adey et al., 1994; Goodier, Ostertag, Du, & Kazazian,
2001; Kingsmore et al., 1994; Kohrman et al., 1996; Loeb et al., 1986; Naas et al., 1998;
Shehee et al., 1987; Takahara et al., 1996). The most recent comprehensive bioinformatic
analysis classified over 20,000 copies of L1 across the mouse genome and grouped them
into 29 families based on their homology in 5'UTR (Sookdeo et al., 2013). The majority
of subfamilies are over one-million-years old in the mouse genome, and many elements
are believed to have lost their activity and become fossil DNA by accumulated mutations
disrupting coding protein or core promoter sequences. Although there are massive copies
of L1 in the mouse genome, only about 3,000 copies of full-length mouse L1s are
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believed to possess retrotransposition capability. All of them belong to TF, GF, and A
subfamilies (Goodier et al., 2001; Richardson et al., 2017). However, the activity profile
across those subfamilies is still unclear.

16. Monomoraic mouse L1 promoter
It is worth noting that mouse L1 has significantly different promoter structures
than humans, regardless of highly similar ORFs across human and murine sequences.
Mouse L1 contains a variable number of monomers, short repetitive sequences around
200 bp length with a non-monomeric tether region upstream of the ORF1 starting
position (Shehee et al., 1987). Structurally, the mouse L1 promoter is more complicated
than the human L1 promoter. Murine L1 promoters contain a variable number of ~200 bp
tandem repeats called monomers (Loeb et al., 1986; Schichman, Adey, Edgell, &
Hutchison, 1993; Shehee et al., 1987). An increasing number of monomers could elevate
the transcriptional activity, and two monomers are the minimal requirement for detectable
promoter activity (DeBerardinis & Kazazian, 1999). In the genome, monomers could be
wholly identical or highly similar but not identical. The distinct homology within
monomers is specific for different subfamilies in the mouse genome (Sookdeo et al.,
2013). Notably, there is also a ~200 bp non-monomeric "tether" sequence between
monomers and ORF1.
As previously discussed, L1 retrotransposition begins with transcription, which is
subject to epigenetic regulation. Previous studies showed higher L1 RNA expression in
male/female germ cells than somatic tissues, indicating that transcriptional regulation is
critical during development. Although human and mouse L1 5'UTRs lack significant
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homology, they both share a YingYang1 (YY1) transcription factor binding motif in their
promoter sequences (only mouse F type promoter has YY1 binding motifs).
Coincidently, intact YY1 is critical for L1 transcription activity in both humans and mice
(Athanikar et al., 2004; Becker et al., 1993; Lee, Cho, Shannon, Fan, & Rangasamy,
2010). Still, mouse L1 promoters have not been well characterized due to the large
number of L1 copies in the mouse genome, and technical challenges of amplifying those
highly similar repetitive sequences from the mouse genome.

17. Closing remarks
McClintock's discovery of 'jumping genes' (DNA transposons) from maize
revealed the intrinsic instability of genomes due to endogenous DNA elements
(McClintock, 1950, 1956, 1978). Despite the skeptics that classified TEs as parasitic
DNA or 'junk DNA', McClintock observed the capability of 'jumping genes' to influence
other genes’ expression in maize (McClintock, 1956). Later studies demonstrated TEs
could be globally involved in gene expression across plant and mammal genomes.
The completion of the sequencing projects for the human and mouse genomes
revealed the massive copy number of TEs in each (Lander et al., 2001; Mouse Genome
Sequencing et al., 2002). L1, the only active autonomous and the largest group of TEs in
the human genome by mass, is strongly associated with human and mouse pathogenesis
(Gagnier, Belancio, & Mager, 2019; Hancks & Kazazian, 2016; Kohrman et al., 1996;
Takahara et al., 1996; Yajima et al., 1999). Although over a hundred individual disease
cases have been reported previously involving hyperactive L1 insertions in pathological
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tissues, there is still a lack of comprehensive understanding of the role of L1 in
pathogenesis and the frequency of L1-mediated diseases.
The mouse is the ideal model for studying the L1 pathological impact in vivo.
Mouse L1 shares similar overall sequence organization and conserved ORF regions with
human L1, except for the significant difference in 5'UTR (Martin et al., 2003; Martin &
Bushman, 2001; Schichman et al., 1993). Besides, both human and mouse L1s evolved
similarly in a single dominant lineage (Adey et al., 1994; Sookdeo et al., 2013).
Previously established mouse models, using pathogenetic human L1 as transgenes, had
relatively low insertion events during the mouse life span (Kano et al., 2009; Ostertag et
al., 2002). Our lab has established a synthetic L1 transgene with the CAG promoter, and
the artificial L1 element showed exceptional activity in vivo (An et al., 2006). However,
the CAG promoter has a distinct difference with the mouse L1 promoter. More
importantly, the L1 promoter plays a critical role in initiating retrotransposition and is
subject to epigenetic modifications (Athanikar et al., 2004; Hata & Sakaki, 1997; Lee et
al., 2010; Newkirk et al., 2017; Wissing et al., 2011; Wylie et al., 2016; Yakovleva et al.,
2004; Yang et al., 2003). An active endogenous L1 with its native promoter is still the
ideal transgene to study in vivo. Although several individual elements have been well
described, our understanding of L1 activity across different subfamilies in the mouse
genome remains inadequate (Adey et al., 1994; Naas et al., 1998; Schichman et al., 1993;
Sookdeo et al., 2013).
Before study of L1 biology in vivo with mice, it is urgent to profile endogenous
L1 retrotransposition frequency and its transcriptional activity across the mouse genome.
We overcame the technical challenges to amplify repetitive sequences from the mouse
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genome, and established sensitive reporter assays to evaluate both retrotransposition and
transcriptional activity across young L1 subfamilies that are predicted to be active based
on linkage analysis (Sookdeo et al., 2013). We also provided detailed sequence function
analyses of individual monomers, tether, and subdomains in the L1 promoter.
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Chapter 2
Profiling promoter activity of different L1 families in the mouse genome

Abstract
Long interspersed elements type 1 (LINE-1s, L1s) occupy approximately 17% of
the human genome, and the majority of these L1s are inactive due to 5' truncation and
other mutations. Recently, targeted or whole-genome sequencing has revealed abnormal
L1 activities across multiple cancer types. Animal models are critical for investigating L1
insertion events and the associated consequences in vivo. Although specific mouse L1
loci have been reported and characterized, the mouse genome's overall L1 activity profile
is still not clear. There are at least 29 mouse-specific L1 families, eight of which could be
capable of retrotransposition. In this project, we aim to investigate and compare promoter
activities of different mouse L1 subfamilies. The rationale is that transcription is the
initial and critical regulatory step for active retrotransposition. A streamlined cloning
method was established for screening the promoter activity. We have cloned a large
number of full-length L1 elements across all potential active L1 families from the mouse
genome and subcloned promoters from those L1 loci. A dual-luciferase reporter system
was utilized, in which the firefly luciferase signal indicates promoter activity, and the
Renilla luciferase signal serves as a control for transfection efficiency. By highthroughput dual-luciferase assay, we can investigate L1 promoter activity. In addition to
evaluating the importance of promoter to retrotransposition activity, we also investigated
the sequence determinants of promoter activity among different mouse L1 families.
Furthermore, we partially revealed factors that can influence promoter activity.
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Introduction
Long interspersed elements type 1 (LINE1s, or L1) are extensively harbored in
mammalian genomes. L1s are the dominant class in autonomous transposable elements,
which comprise roughly 17% and 19% in human and mouse genomes, respectively
(Lander et al., 2001; Mouse Genome Sequencing et al., 2002). L1s have been amplified
in mammalian genomes during radiation of mammalian species, and are the only active,
autonomous retrotransposons in the human genome (Smit, 1996). Although the human
genome has accumulated over 500,000 copies of L1 sequences (Grimaldi, Skowronski, &
Singer, 1984; Mouse Genome Sequencing et al., 2002), only 80 ~ 100 copies still are
potentially active and tested by in vitro study (Brouha et al., 2003; Sassaman et al., 1997).
Due to the diversity of the human population, each individual may host additional active
L1s (Beck et al., 2010; E. C. Scott et al., 2016). In contrast, about 3,000 copies of fulllength L1s are potentially active in the mouse genome (Goodier et al., 2001). Still, in
both human and mouse, the vast majority of L1 elements cannot generate novel insertions
caused by 5'-truncation, mutations and rearrangements (A. F. Scott et al., 1987). An
active L1 typically is about 6 kb in length (Brouha et al., 2003; Dombroski et al., 1991).
Full-length human L1 contains a 5' untranslated region (5'UTR), which is an internal
promoter (Minakami et al., 1992; Swergold, 1990), open reading frames (ORFs) and 3’
untranslated region (3’UTR). An intact L1 retrotransposition lifecycle starts from its
internal promoter located within 5’UTR to initiate transcription (Lander et al., 2001),
followed by transport of the mRNA to the cytoplasm. ORF1 and ORF2 are two major
proteins encoded by L1 to assist its mobilization in cis preference (Holmes, Singer, &
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Swergold, 1992). ORF1p is relatively smaller (~40 kDa) (Khazina & Weichenrieder,
2009) and has a high affinity of RNA binding activity (Kolosha & Martin, 2003; Martin
& Bushman, 2001). Also, ORF1p has chaperone ability and accelerated annealing
function in mouse L1 retrotransposition (Feng et al., 1996). ORF2p, a 150-kDa protein
encoded by L1, has endonuclease (EN) (Mathias et al., 1991) and reverse transcriptase
(RT) domains (Luan et al., 1993) which are critical for novel insertions. Then, RNP
assembly with ORF1, ORF2, and L1 mRNA allows reentry into the nucleus to initiate L1
integration in the host genome through a target-primed reverse transcription (TPRT)
mechanism (Cost & Boeke, 1998). During the TPRT process, EN cleaves on the bottom
strand of genomic DNA to generate a single-strand nick at the consensus cleavage site of
5’-TTTT/A-3’ (Feng et al., 1996; Gilbert, Lutz-Prigge, & Moran, 2002; Morrish et al.,
2002; Symer et al., 2002). After the enzymatic cleavage, the 3' end nick site will be
utilized to begin the reverse transcription process with the L1 RNA template.
Although many pathological de novo L1 insertion events have been reported
recently in somatic tissues (Kazazian et al., 1988; X. Li et al., 2001; Miki et al., 1992; E.
C. Scott et al., 2016), previous studies showed that L1 mRNA and ORF2p are dominantly
expressed in germ cells (Branciforte & Martin, 1994; Trelogan & Martin, 1995). The
consensus is that most L1 retrotransposition events happen during early embryogenesis. It
has been confirmed by whole genome sequencing in human somatic tissue that L1 can
disrupt the tumor suppressor gene and initiate colorectal cancer (E. C. Scott et al., 2016).
Hypomethylation of those hot donor L1s in the patient's genome might be the potential
reason for L1 evading suppressing machinery in somatic tissue, but this is uncertain.
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Besides, neurofibromatosis type 1 is one of the most common genetic diseases and can be
directly caused by L1 insertions (Hancks & Kazazian, 2012).

Hence, the in vivo mouse model is urgently needed and critical for study of timing
and pathological impact in vivo induced by L1 retrotransposition events. Since the early
21st century, when the first transgenic mouse model with the human L1 element was
proposed (Ostertag et al., 2002), it is always interesting to observe that with human L1
5'UTR, only transgene expression in gonads is detected rather than in any somatic tissues.
However, with an additional Pol II promoter on endogenous 5'UTR, transgene expression
in somatic tissues can be observed. Since then, scientists have generated a mouse model
with codon optimized synthetic mouse L1 ORFs and driven by a CAG promoter (An et
al., 2006). One of the most recent transgenic mouse models is built with an endogenous
mouse promoter, and previous hyperactive codon optimized ORFs (Newkirk et al., 2017).
Nevertheless, if the full regulatory picture can only be addressed with the endogenous L1
transgene, details remain unclear.
Even now, after over a decade of investigation, most active mouse L1s (L1spa,
GF21) are from TF and GF subfamilies (Goodier et al., 2001) based on in vitro activity test
results. Researchers have successfully captured L1 retrotransposition events with fulllength mouse L1 GF21 (Kano et al., 2009) and 5’UTR of L1spa (Newkirk et al., 2017).
Also, researchers have successfully traced a few TF germline insertions across several
generations in the laboratory mouse genome (Richardson et al., 2017). However, those
insertions of donor L1s are much less active than GF21. A recent study using an L1
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transgene, driven by a heterologous promoter CAG, showed abundant L1
retrotransposition events in the mouse model (An et al., 2006).
Further study (Newkirk et al., 2017) revealed that using the single-copy mouse L1
5'UTR transgene can maintain similar methylation dynamics with endogenous L1.
Consequently, it seems that 5'UTR has a significant role in the alignment of global
methylation status, one of the most critical epigenetic markers. The latest study provided
persuasive evidence to demonstrate that the YY1 binding site on the human L1 promoter
is critical for the whole promoter’s methylation level (Sanchez-Luque et al., 2019).
Furthermore, transcription from 5'UTR is the initial and critical step to start an entire L1
retrotransposition event. Without a broader understanding of the promoter activity
spectrum of active L1 subfamilies, the current activity status of L1 elements in the mouse
genome remains unclear. It is crucial and urgent to have a study that comprehensively
profiles the promoter activity across mouse L1 subfamilies.
All previous evidence shows the importance of the 5'UTR for the L1
retrotransposition event. After the evolutionary process in the past ~70 M years leading to
divergence of L1s in human and rodent, ORFs are still preserved with high sequence
similarity between both. However, it remains a mystery as to why there are structurally
dramatic differences between human and mouse L1 5'UTR.
The mouse L1 promoter has tandem repeat sequences, which are also called
monomers. Monomer number varies over a broad spectrum in the mouse genome.
Previous cell assays have shown that a 2-monomer is the minimal promoter structure to
have significant activity (DeBerardinis & Kazazian, 1999). On the monomer's
downstream side are found nonmonomeric tether sequences on the boundary to separate
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ORFs and monomers. In both A-type and F-type mouse promoters, the tether does not
have significant transcriptional activity (DeBerardinis & Kazazian, 1999; Severynse,
Hutchison, & Edgell, 1992). Currently, only one subfamily remains active in the human
genome, while there are several active subfamilies in the mouse genome. (Sookdeo et al.,
2013). Due to greater complexity of the abundant L1s in the mouse genome, they have
not been well studied and compared across subfamilies. Hence, we are trying to profile
the promoter activity in 7 young subfamilies. Potentially, this study provides a foundation
for further biological study of L1.
Compared with mouse L1 subfamilies, only two different lineages (L1PA and
L1PB) co-existed (Khan et al., 2006) in ancestral primates' genomes. Ta is the single
lineage still active in the modern human genome. The transition process from multiple
lineages to a single lineage still remains unknown. Unlike the human genome, the mouse
genome currently has two non-homologous lineages (L1MdA and L1MdTF/GF) that are
active, and not comprehensively studied. The study of mouse L1 biology could elevate
our understanding of human L1s. The 5'UTR is vital in both the human and mouse L1 life
cycle, which requires a fairly large number of transcripts to initiate the reverse
transcription process.

Material and methods
Backbone vector construction
We started with designing restriction site overhanging primers (WA1312 and
WA1314) that can amplify a firefly luciferase cassette from pGL4.13 (Promega) with
AvrII and KpnI restriction sites on 5' and 3' ends of the PCR product respectively.
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WA1312 has AvrII restriction site sequences, while WA1314 has KpnI restriction site
sequences. We then digested both the PCR product and pLK003 plasmids with a double
restriction digest reaction (AvrII and KpnI). The PCR product is an insertion fragment,
and the larger fragment from pLK003 is the backbone. After T4 ligation of these two
fragments, we successfully cloned the vector so that the firefly luciferase cassette is
driven directly by any insertion fragment cloned into the two SfiI restriction enzyme
cleavage sites. We have also included a SfiI sequence (5’-AGGCCAAAATGGCC-3') to
WA1312 forward primer to fix the original upstream SfiI restriction site destroyed in the
cloning process. The rest of the vector is identical with pLK003, and still, the vector has a
dual-luciferase cassette (Fig. 1).

Insertional fragment
We used the same PCR cycle to amplify only the promoter region from fulllength L1 elements with SfiI overhang primers (details in chapter 2). All amplified
products were purified with gel electrophoresis followed by extraction, and then were
digested with SfiI restriction enzyme (NEB). After overnight digestion, we used
QIAquick PCR Purification (QIAGEN) to remove all unexpected residues, and to remove
the enzyme and other residues. Purified promoter fragments were ligated by T4 ligase
(NEB) with promoter vector.
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Figure 1. L1 promoter dual-luciferase plasmid constructed. L1 promoter directly drives
the firefly luciferase cassette (Fluc), while Renilla luciferase (Rluc) is driven by an
independent promoter HSVTK and serves as an internal control.

L1 promoter dual-luciferase cell assay
For human HeLa and mouse F9 cells, we started with seeding 2.4 × 104 cells per
well in a 96-well plate and prepared a lipid complex for transfection (0.2 µl P3000, 0.3 µl
Lipofectamine and 10 ng plasmid per well). This was mixed well with gentle shaking of
the plate and incubated for 24 hours. After incubation, cells were harvested and lysed. A
dual-luciferase reporter assay protocol (Promega) was followed for further signal
detection. We extended incubation time for mouse 3T3 cells from 24 hours to 48 hours
for optimized expression levels.
After incubation and washing, 20 µl cell lysis buffer was added to each well in a
96-well plate. To avoid high background in empty wells, we conducted all steps in
darkness. Incubation was at room temperature (~21 Cº) with gentle shaking for 15
minutes. Then sequential measurement of firefly luciferase and Renilla luciferase was
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conducted by adding 100 µl Luciferase Assay Reagent II and 100 µl Stop & Glo Reagent.
Both readings were done with the GloMax Multi Detection System (Promega).

L1 loci selection
We utilized the bioinformatics method to filter potential active full-length L1
elements from the mouse genome, and to establish our sampling method to clone some
representative elements from the mouse genome (details in Chapter 3 Results). For this
chapter, we subcloned the promoter region from each L1 element and put it into a dualluciferase reporter vector designed for transcription assay.

Statistics
All statistical analysis was done with Excel by using two-tailed unpaired T-tests
to determine if there was a significant difference between two clones (each clone having
four biological replicates). We always specified the alpha level as 0.05 in the statistical
test. Mean was calculated by taking the average of four biological replicates. Data
consistency was tested with the Standard Deviation (SD) function, using Excel.

Results
The vast majority of full-length L1s from young mouse L1 subfamilies possess two
monomers
Previous studies have shown that mouse L1 promoter activity requires at least two
monomers based on L1spa (TF subfamily), and that promoter activity is proportional to
monomer number in 5'UTR (DeBerardinis & Kazazian, 1999). The most recent
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bioinformatic analysis for the L1 phylogenetic tree demonstrates the evolutionary pattern
for mouse L1 subfamilies (Sookdeo et al., 2013). Since old subfamilies have accumulated
many mutations and eventually lose their activity, we decided to focus on relatively
young and potentially active subfamilies (Fig. 6 in Chapter 2). Due to the massive copy
numbers of L1 elements in the mouse genome, there is no study to show monomer
numbers’ distribution across different subfamilies. As the first step to understanding
mouse promoter activities, we analyzed the length distribution of mouse 5'UTR
promoters by counting the number of monomers for seven L1 subfamilies, including A_I,
TF_I, TF_II, GF_I, TF_III, A_II, and A_III (ordered by age from young to old) (Fig. 2).
Elements were binned according to their respective 5' start points. For example, if the
5'UTR of an element started within the third monomer, it was counted as a monomer 3
(M3) element. There was a trend of length reduction as a subfamily's age increased
(shifted from long to short). The vast majority of A_I elements, the youngest among this
group, had at least two intact monomers. The distribution of A_I elements peaked at M3.
In other words, more elements started within the third monomer than any other 5'UTR
positions. In contrast, A_III elements, the oldest among this group, had fewer than two
intact monomers, and a large number of the elements start in the second monomer.
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Figure 2. Monomer number of L1 promoter distribution patterns across seven young
subfamilies. (A) Monomer counting of mouse endogenous L1 promoter from A_I, A_II,
and A_III subfamilies. (B) Monomer counting of mouse endogenous L1 promoter from
TF_I, TF _II, and TF _III subfamilies. (C) Monomer counting of mouse endogenous L1
promoter from GF_I subfamily.
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This shortening trend was also evident if a comparison was made within closely
related subfamilies. At the extreme end of the spectrum, there are seven loci with over ten
intact monomers, all from the young A_I, TF_I, TF_II, and GF_I subfamilies.
Monomer number could be varied with a broad spectrum in the mouse genome, as
a cell assay has shown the 2-monomer is the minimal promoter structure to have
significant activity (DeBerardinis & Kazazian, 1999). On the downstream side of the
monomer are the nonmonomeric tether sequences on the boundary to separate ORFs and
monomers. In both A-type and F-type mouse promoters, the tether does not have
significant transcriptional activity (DeBerardinis & Kazazian, 1999; Severynse et al.,
1992).

Comparative analysis of promoters from young L1 subfamilies
To quantitatively evaluate L1 promoter activity, we developed a single-vector
dual-luciferase reporter assay. In this vector design, a variant of L1 promoter drives
firefly luciferase (Fluc) expression, and a heterologous HSV-TK promoter drives the
expression of the Renilla luciferase reporter (Rluc). The latter cassette is embedded in the
plasmid backbone as an internal control for normalizing transfection efficiency. The L1
promoter activity is reported as the Fluc/Rluc ratio. For this assay to work appropriately,
both Fluc and Rluc signals must not be saturated, and there is minimal crosstalk between
the two cassettes. We performed a titration experiment with 5-30 ng of pCH117 plasmid
per reaction (Fig. 3A-C). The Fluc and Rluc signals scaled proportionally with an
increasing amount of plasmid transfected, and the Fluc/Rluc ratio showed little change

52
across this range. Note the L1 promoter in the pCH117 plasmid is derived from an active
human L1, L1rp, which we used in L1.

Figure 3. L1 promoter dual-luciferase vector titration experiment in 3T3 cells. (A)
Normalized promoter activity by using Fluc raw signal over Rluc raw signal. With the
various plasmid amounts transfected from 5 ng to 30 ng (per well in 96-well plate), the
normalized value showed undependability of plasmid amount and validated our assay.
(B) Raw signal from Fluc luciferase assay versus the different plasmid amount is
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transfected from 5 ng to 30 ng (per well in 96-well plate). (C) Raw signal from Rluc
luciferase assay versus different plasmid amounts transfected from 5 ng to 30 ng (per
well in 96-well plate).
Retrotransposition assay was used as well to keep the control consistent
(Kimberland 1999 HMG). We used it as a positive control as it displays nearly the
highest promoter activity relative to the vast majority of the mouse L1 promoters we have
tested. In subsequent assays, 10 ng was used per reaction in a 96-well assay format.
As the first attempt to compare promoter activities across young subfamilies (A_I,
A_II, A_III, TF_I, TF_II, and GF_I), we synthesized and subcloned the consensus
promoter sequence of each subfamily into the dual-luciferase vector (Fig. 4). As the
length of the consensus 5'UTR varies among these subfamilies, we retained only the first
two monomers plus the tether in our assay. This decision was based on two observations.
First, for the L1spa element, a minimum of two monomers are required for detectable
promoter activity (DeBerardinis & Kazazian, 1999). Second, as we described earlier,
most of the elements from the young L1 subfamilies retain at least two intact monomers
(Fig. 2). The highest activity was found for the 2-monomer consensus of TF_II (about
40% of L1rp), followed by TF_I (37% of L1rp), A_I (about 30% of L1rp), TF_III (about
20% of L1rp), A_II (about 16% of L1rp), and the lowest activity was found in the 2monomer consensus of GF_I subfamily (less than 10% of L1rp). Overall, there is a
modest inverse correlation between subfamily age and 2-monomer consensus promoter
activity among the six subfamilies (R2 = 0.47). The three youngest subfamilies (A_I,
TF_I, and TF_II, with age range 0.21-0.27 Myr) have similar activities. The two older
subfamilies (TF_III and A_II, ranging 1.23-1.62 Myr) have reduced activities (50-60% of
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the former group). The exception is found in GF_I, which is relatively middle-aged (0.75
Myr) but showed significantly less activity (17% of TF_II).

Figure 4. Promoter activity comparison across six subfamilies by synthetic 2-monomer
consensus. We synthesized a 2-monomer structure with a tether from each young
subfamily and cloned into the reporter vector. We also included L1rp, which is
normalized to 1000, while backbone vector activity is around 1 on the scale.

We compared the promoter activities of multiple young L1 subfamilies using
synthetic consensus two monomer sequences. The consensus constructs are likely to
represent the ancestral state of the respective promoter subfamily. Computation analysis
indicates that some genomic copies retain the consensus sequence. Nevertheless, the vast
majority of the genomic copies contain different numbers of mutations compared to the
consensus sequence. To gain a more comprehensive understanding of the current mouse
L1 promoter's potential in the genome, we decided to clone some representative L1
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promoters from full-length L1s. The elements were selected from a large set of loci
capable of undergoing de novo insertions in the mouse genome (details in Chapter 3).
The screening criteria included (1) full-length, and non-recombined, (2) with at least two
intact monomers, (3) full-length ORF1 and ORF2 coding sequences (detailed in
Methods). By testing with our high-throughput dual-luciferase assay, we measured their
activities in HeLa cells (full-length L1 retrotransposition also measured with HeLa), 3T3,
and F9 cell lines. Overall, the F type of promoters was underestimated by using the HeLa
cell line (Fig. 5). As a human cell line, HeLa cells could lack supportive transcription
factors and not be a suitable environment for F type promoters, which further discourages
downstream retrotransposition activity. On the other hand, 3T3 and F9 are highly similar
in our data's promoter activity profile. For the 3T3 cell line, the exceptionally active
promoters are all from TF_II, consistent with the previous two monomers’ consensus test.
A_I, as one of the youngest subfamilies, had much less diversity of the activity spectrum.
However, TF_II had a broader activity spectrum, likely due to its longer history in the
mouse genome generating a wide distribution of different variants. We can also find that
almost all young subfamilies have a small fraction of promoters that are not active, while
they have intact ORFs. This might explain why only a certain number of L1 loci are
retrotranspositionally active, despite the massive copy number distributed in the genome.
Interestingly, all promoters tested from TF subfamilies were suppressed in the HeLa cell
line. Some transfection factors do not provide a supportive environment for TF promoter
transcription, and those factors exist in the mouse cell line 3T3. We cloned the flanking
sequences with target site duplicate (TSD) in all promoters, and it was helpful for
understanding the promoter activity with the original genome location. For those flanking
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sequences adjacent to L1 loci, it would be interesting to test if they impact promoter
activity in vitro. Previous studies have shown that flanking sequences can strongly
influence the human L1 promoter (Lavie, Maldener, Brouha, Meese, & Mayer, 2004).
We have cloned four different L1 promoters from the A_I subfamily and compared them
with or without upstream flanking sequences. Those promoters have different lengths and
have different point mutations, but they are consistent in having upstream sequences (Fig.
6). Others are significantly more active with upstream sequences except for pLK025, and
pCH060 has an insignificant p (p>0.05) value.

Figure 5. Promoter activity comparison across six subfamilies by subcloned promoters
from Chapter 2. We subcloned 80 promoters from the full-length L1 elements (details in
Chapter 3) and measured with our dual-luciferase reporter. All promoters were grouped
by subfamily and distinguished by different colors. Each data point has four replicates,
and we only represent the average activity of four replicates.
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Figure 6. Upstream flanking sequences impact on L1 promoter activity. Triangle with a
number represents the length of the flanking sequences for each L1 promoter. An open
square indicates each monomer's length, while the solid grey square is the highlight for
tether structure.

Monomer 2 is essential for L1 promoter activity.
Most L1s across young L1 subfamilies retained more than two monomers but are
rather striking (Fig. 4). Our results are consistent with the previous report that the 2monomer is required for L1 promoter activity (DeBerardinis & Kazazian, 1999).
However, the previous study was based on a single promoter variant, L1pa, which is a
prototype of mouse TF elements (Naas et al., 1998). To reclassify it based on the new
subfamily definition, we attempted pairwise alignment with TF_I and TF_II reference
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sequences. L1spa had similar levels of divergence to TF_I and TF_II in 5'UTR, but a
much higher similarity to TF_I than to TF_II in 3'UTR. Most likely, L1spa belongs to the
TF_I subfamily. To validate and expand previous findings, we conducted similar studies
with consensus promoters for three different subfamilies, including A_I, TF_I, and GF_I.
To determine the two individual monomers' contribution to the promoter activity for
other subfamilies, especially for those youngest subfamilies which are broadly distributed
in the mouse genome with potential mobility; and to avoid the aging impact from single
nucleotide neutral mutations accumulated in the mouse genome, we decided to use the
consensus sequences to apply in this experiment. In most cases, the first and second
monomer from each promoter was slightly different in both length and sequences, which
could potentially be the reason for the difference of promoter activity.
In the A_I subfamily, the 2-monomer construct (pKL049) displayed a 25-fold
higher activity than the one monomer construct (pLK040) (Fig. 7), consistent with the
previous report with L1spa. Then we looked at the activities of each domain: M2, M1,
and Tether alone. Surprisingly, the second monomer of A_I (pLK053) showed
remarkable promoter activity, with 4.3-fold higher activity than the 2-monomer construct.
In contrast, the M1 (pLK052) and tether (pLK041) had a low but detectable amount of
activity relative to a control vector lacking a promoter sequence (pLK037; i.e., "nopromoter control"). Specifically, both had less than 3% of the 2-monomer promoter but
were still 7-8-fold above the no-promoter control vector (p < 0.05, 2-tailed t-test for M1
and Tether versus control). Our backbone control plasmid (pLK037), a self-ligated
backbone vector, showed little background signal in our measurement. Thus, we
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conclude that M2 alone has remarkable activity and is critical for the L1 promoter
activity.

Figure 7. A_I components for promoter activity test. pLK042 has flipped tether
sequences from TF_I. pLK052 and 053 are the first and second monomer of AF_I,
respectively. pLK049 is the 2-monomer consensus of A_I, while pLK040 is a 1-monomer
consensus of TF_I.

To further confirm such residual promoter activities, we included two additional
control plasmids (Fig. 8). First, we replaced the promoter sequence with a 202 bp
fragment from the GFP coding sequence (pLK043), equivalent to the length of A_I
tether. As expected, this 202-bp GFP sequence showed little promoter activity (at ~70%
of the activity relative to the no-promoter control vector). In contrast, similar to the
previous trial, the A_I tether (pLK041) had a 6.7-fold higher activity relative to the nopromoter control vector (p < 0.05). Second, we inverted the tether sequence in the
reporter construct (pLK042). Interestingly, the antisense A_I tether had a 3 to 4-fold
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higher activity than the no-promoter control. These results suggest that the A_I tether
sequence has weak transcriptional activities in both sense and antisense orientations.
We extended the investigation to other types of L1 promoters. We further tested
the contribution of individual domains for the TF_I consensus sequence (Fig. 9).
Consistent with the previous report, the promoter construct with two tandem monomers
(pLK050; M2-M1-T) showed 5.5-fold higher activity than the construct containing the
first monomer and the tether (pLK047; M1-T). The previous study showed there was
minimal activity from tether alone or M1 alone, and M2 alone was not tested. The high
resolution of our assay allowed us to differentiate the relative activities of M2, M1, and
Tether. In the context of the consensus sequence, M2 alone (pLK057) displayed an
activity equivalent to 27.7% of the M2-M1-T sequence, and M1 alone (pLK056) was
about 2-fold less active (12.7% of M2-M1-T). Tether alone (pLK054) showed even less
activity (5.6% of M2-M1-T) but remained 20-fold above the assay background
(compared to the no-promoter construct; p < 0.05). Like the A_I tether, the TF_I tether
also showed some promoter activity in the antisense orientation (pLK055; 13-fold above
background; p < 0.05).
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Figure 8. Some mouse L1s possess length-dependent promoter activity in our luciferase
assay. pLK033 and pLK043 were coding sequences from GFP. pLK041 is A_I tether,
and pLK042 is flipped pLK041 to test the antisense activity. pLK028, pLK036, and
pLK040 were the series deletion of pCH061.
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Figure 9. TF_I components for promoter activity test. pLK055 has flipped tether
sequences from TF_I. pLK056 and 057 are the first and second monomer of TF_I,
respectively. pLK050 is the 2-monomer consensus of TF_I, while pLK047 is a 1monomer consensus of TF_I.

The third active mouse L1 family is GF (Goodier et al., 2001). The reclassified
GF_I subfamily conforms to the pattern II of GF promoters. For A_I and TF_II
subfamilies, we designated the internal, truncated 64-bp monomer as part of the
nonmonomeric tether sequence (313 bp). A similar trend was observed in the GF_I
promoter (Fig. 10). As described earlier, the consensus 2-monomer construct (pLK051)
had a much weaker promoter activity than TF_I and A_I 2 monomer constructs (18.5%
and 22.3%, respectively). Nevertheless, it remained more active than the 1-monomer
construct (pLK048; 3.5-fold). The magnitude of reduction was not as dramatic as A_I
and TF_I. The activities of individual domains, M2 (pLK063), M1 (pLK062) and 313 bp
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Tether (pLK060), ranged from 11.6-17.4% of the 2-monomer promoter (p < 0.05). The
antisense 313 bp Tether (pLK061) had slightly higher activity than the tether (24.6% of 2
monomers). We also subcloned the tether sequence without the 64 bp truncated
monomer. The shortened 249 bp tether had a detectable amount of activity in both sense
(pLK058; 13% of the 2-monomer promoter) and antisense orientation (pLK059; 15.6%).
To further demonstrate the incomplete monomer's role for most young L1
elements, we synthesized consensus monomers (one/two-monomer for A_I and threemonomer for A_I/TF_I). Also, we cloned different lengths of incomplete monomers to
compare the activity. The data (Fig. 11A-B) are consistent with the previous test. This
shows that the first 40 bp (more precisely is the 20~40 bp of 5’end) are very critical for
promoter activity for both the single monomer and two-monomer A_I promoter. It is
worth noting that although the first monomer and tether showed some level of promoter
activity in the previous test, still the second monomer is predominant in promoter
activity.
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Figure 10. GF_I components for promoter activity test. pLK061 is the flipped sequence
of GF_I full-length tether (pLK060). We also tested the partial tether sequence (pLK058)
and its flipped version (pLK059) by removing a short repeat sequence which shows
homology with monomers. First, GF_I monomer (oLK062) and second GF_I monomer
(pLK063) were also tested independently. pLK051 and pLK048 are 2-monomer and 1monomer consensus promoter structure, respectively.

Monomer 1 and tether have promoter type-dependent role in promoter activity
Across all three subfamilies, two monomer constructs were much more active
than the corresponding one-monomer constructs. Besides, for individual promoter
components (M2, M1, and tether), M2 was consistently more active than the
corresponding M1 and the tether for each subfamily. However, we noted that the
interactions between the individual promoter components were complex and vary among
the three subfamilies. For A_I subfamily, the activity of M2 alone was even more active
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than the two monomer promoter structure, but M1 or the tether alone only had weak
promoter activity, suggesting that the presence of M1 and tether muffled M2 activity,
resulting in 4.3-fold lower activity in the 2-monomer construct (Fig. 7). Since the tether
has nonmonomeric sequences and its function remains unknown, we decided to test the
tether's role in promoter activity, by generating a synthetic construct in which the second
monomer is placed directly upstream of the tether (pLK046). The presence of tether
sequence reduced M2 activity by 5.4-fold (Fig. 7), indicating that the A_I tether
significantly suppresses the promoter activity of M2 (p < 0.05). Thus, it is evident that
M2 is the major contributor of 2-monomer promoter activity, while M1 and tether or
tether alone negatively regulate M2 activity in a 2-monomer sequence. Notably, it seems
that the activity of M1+T is the sum of M1 and T alone, suggesting an additive role.
Compared with the second monomer alone, the promoter activity declined over
70%. We tried to regenerate the same constructs in TF subfamilies (TF_I and TF_II).
Unlike A_I, adding tether in TF monomers favored promoter activity in varying degrees
(Fig. 12). In both pLK073 and pLK074, we observed significant increases in promoter
activity when adding tether sequences (p < 0.05, Fig. 12). Although in pLK075, the pvalue was statistically significant, a slight increase in average activity based on the four
biological replicates was observed.
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Figure 11. 5’ end monomer deletion study. (A) Series deletion study on 2-monomer
(A_I) consensus, where each time we deleted 20 bp and measured the promoter activity.
(B) Series deletion study on 1-monomer (A_I) consensus, where each time we deleted 20
bp and measured the promoter activity.
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Figure 12. Tether’s role of L1 promoter activity (F type). pLK078 is the M2 from
synthetic TF_II consensus (M2+tether, pLK075). pLK077 is the M1 from TF_II
consensus (M1+tether, pLK074). We also included a TF_I promoter with a point mutation
with consensus (pLK073 and pLK076). pLK076 is the M2 from synthetic TF_I promoter
(M2+tether, pLK073).
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Figure 13. Third incomplete monomer influences promoter activity. (A) 3-monomer
consensus (pLK085) from A_I compared with a series deletion on 5' end (40 bp stepwise
deletion). (B) 3-monomer consensus (pLK086) from TF_I compared with a series
deletion on 5' end (40 bp stepwise deletion).
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To study the impact of an incomplete monomer on the overall promoter activity,
we created a series of A_I and TF_I promoter constructs (Fig. 13A-B) by truncating the
third monomer stepwise for 40 bp. The 3-monomer consensus construct was more active
than the 2-monomer consensus construct (3.2-fold and 1.7-fold for A_I and TF_I,
respectively; Fig. 13A-B). The deletion of the first 40 bp (pLK090) significantly reduced
the promoter activity to 43.6% of the 3-monomer construct. The first 80 bp (pLK091)
removal reduced the promoter activity further to 17.8% of the 3-monomer construct. The
deletion of the first 120 bp (pLK092) had a similar effect (15.3% of the 3-monomer
construct). However, this diminishing trend was reversed when the promoter was further
truncated. The promoter activity was restored to 23.3% of the 3-monomer construct when
the first 160 bp were deleted (pLK093). The deletion of the entire third monomer (208
bp), equivalent to the 2-monomer construct (pLK049), restored the activity to 31.4% of
the 3-monomer construct. Similar patterns were seen with the vector series for TF_I (Fig.
13B). The promoter activity was reduced to 78.1%, 40.0%, and 36.5% of the 3-monomer
construct with 40 bp, 80 bp, and 120 bp deletions, respectively, and then rebounded to
41.3% and 59.7% of the promoter activity with 160 bp and 212 bp deletion.
Interestingly, both subfamilies shared the same pattern where the first 40 bp
positively impacted overall promoter activity, and the incomplete monomer suppressed
promoter activity if its length did not contain the first 40 bp, which was not observed in
the previous test.
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Figure 14. Mouse L1 promoter activity influenced by incomplete monomer despite
incomplete monomer itself having no significant activity in the previous study. Three
endogenous L1 elements with 3 or 4 monomers were included in this test (pCH064,
pCH060, and pCH061). (A) pCH061 series deletion study. (B) pCH060 series deletion
study. (C) pCH064 series deletion study.
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To investigate how additional monomeric sequences could impact endogenous L1
promoters' activity, we cloned three A_I promoters from the mouse genome and
performed truncation analyses.
Clone pCH061 possessed 3.5 monomers (Fig. 14A). It deviated from the A_I
consensus sequence by possessing one SNP in its third and second monomer. In contrast,
its first monomer and tether were identical to the A_I consensus sequence. When it was
initially cloned, pCH061 had 82 bp of upstream flanking sequence, including 12 bp of
target site duplication. The flanking sequence's removal reduced the promoter activity by
1.4-fold, indicating that the upstream sequence had an impact.
Further deletion of the incomplete fourth monomer (pLK028) saw some drop in
transcriptional activity. The deletion of the third monomer (pLK036) further reduced the
promoter activity by 4.4-fold. Although this endogenously derived 2-monomer construct
had only a single SNP relative to the consensus A_I sequence, its activity was
significantly lower, suggesting a potentially important role for this SNP. It is worth
noting that two mutations in pLK028 structure were not expected and might come from
PCR induced mutagenesis. It might have slightly changed the result for pLK028 activity.
Clone pCH060 was an endogenous clone that possessed 3.4 monomers (Fig.
14B). Unlike clone pCH061, it had many more SNPs than the A_I consensus sequence
(2, 6, and 6 SNPs in M3, M2, and M1, respectively). The deletion of the 43 bp upstream
flanking sequence that included 15 bp target site duplication (pLK025) reduced the
activity slightly by 1.1-fold. However, the deletion of the 77 bp third monomer (pLK026)
dramatically increased the promoter activity. On the other hand, removing the second
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monomer reduced the promoter activity down to 27% of the pLK025. Note this twomonomer construct, despite having 12 SNPs relative to the consensus sequence, retained
a significant amount of activity, suggesting mutations might favor L1 promoter activity.
The third clone (pCH064) had 2.9 monomers (Fig. 14C). Relative to the
consensus sequence, it had a total of 7 SNPs scattered across its three monomers (1, 4,
and 2 SNPs in M3, M2 and M1, respectively). The removal of the 76 bp flanking
sequences (including the 12 bp TSD, pLK021) reduced the activity by 2.6-fold. The
deletion of 60 bp from the incomplete 188 bp third monomer (pLK022) nearly abolished
the promoter activity, as it was reduced by 6.3-fold. It only had a point mutation at the 3'
end of the sequences for its incomplete monomer. It seems the incomplete consensus
monomer plays an important role when the rest of the monomer is highly mutated and
loses activity. Further deletions had similar effects. Both the 2.3 monomer derivative
(pLK023) and the 2-monomer derivative (pLK024) showed 13.2% and 15.9% of the
pCH064 activity. It is worth noting that unlike pLK025, the 2-monomer construct
pLK024, which has 6 SNPs, had diminished activity compared to the 2-monomer
consensus. Thus, mutations can either upregulate or downregulate overall promoter
activity.
L1 promoters neutrally have an incomplete monomer at the 5' end. The role and
importance of the partial monomer at 5’ end remains unclear. A previous study has
shown that a single A monomer alone requires intact monomer sequences to have
promoter activity (Severynse et al., 1992). Single monomers have been amplified from
genomic mouse L1 element L1Md_A2/13 (Loeb et al., 1986; Shehee et al., 1987). Since
there are a massive number of A monomer variants in the mouse genome, we conducted

73
studies with a consensus monomer. Also, to confirm the result obtained from the
consensus monomer, we have investigated some individual L1 promoters directly cloned
from C57BL/6J mouse genomic DNA. We have cloned pCH061, pCH060, and pCH064,
all from the A_I subfamily and potentially active in cell culture assay.
We cloned two extreme cases where pCH060 has over 10 SNPs, and in the other
case pCH061 only having 2 SNPs. Both of them have three intact monomers and one
incomplete monomer. Not surprisingly, pCH061 was slightly decreased in promoter
activity, consistent with consensus deletion study. However, for the heavily mutated
variant pCH060, it rebounded to 160% of original promoter activity after deleting the
incomplete monomer (Fig. 14B). This unique case suggests a potential mechanism by
which a novel subfamily emerges from an aged L1 subfamily in the mouse genome.

Discussion
We have developed a high-throughput dual-luciferase assay for L1 promoter
study, which covers all the young and potential active subfamilies. It is the first
comprehensive experimental study for mouse L1 promoters. We have found that a single
monomer can be active by itself (Fig. 7), and the activity that comes from each monomer
is different. By using synthetic consensus sequences, we confirmed the previous classic
study, which was done with L1spa. Comparing promoter activity through synthetic
promoter series confirmed two monomers are the minimal requirement for the TF
subfamily. However, the previous study did not show the rules with different subfamilies.
The non-homologous 3' region of the first monomer makes two monomers contributing
unequally to the promoter activity. Notably, the second monomer from A subfamilies is
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exceedingly active and even more active than two monomers A promoter. As we
observed in this study, the longer and more homologous monomer would be more active
than the first monomer, which is usually shorter and does not have a full unit of repeat
sequences.
Monomers play an essential role in L1 promoter activity, besides other
components and factors that significantly influence promoter activity. A previous study
(Lavie et al., 2004) provided an insight into upstream flanking sequences having a
significant impact on the human L1 promoter activity. Although human and mouse L1s
do not share much homology in their promoters, they have highly conserved regions in
both ORFs. We hypothesized that flanking sequences might provide both positive and
negative impacts on mouse L1 promoters. Unexpectedly, in all four pairs of promoter
activity study, no matter the length and extent of random upstream flanking sequences,
we always observed the upregulating of L1 promoter activity (Fig. 6). Since the mouse
L1 promoter consists of tandem repeat sequences and could benefit from having nonmonotonic upstream flanking sequences, it can potentially generate more transcription
factor binding sites. Due to the limited sample size (we only tested four), we might not
have fully captured all the possible impacts from the upstream sequence.
An incomplete monomer usually can be found at the beginning of mouse L1
5'UTR. In the previous study, the role of those adjacent sequences was not addressed. We
have cloned different length incomplete monomers with two intact monomers, one
monomer and incomplete monomer itself. Our data reveal that the incomplete monomer
could play a significant role, in either promoting or suppressing, promoter activity
depending on the fraction from the full monomer. We can preserve some extent of the
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benefit for promoter activity from having the additional monomer if the incomplete
monomer is longer than 168/208 bp. Conversely, having an incomplete monomer, which
is shorter than 168/208 bp, will suppress the promoter activity.
In our assay, the tether had insignificant promoter activity, although it may have
some extent of transcription activity evidenced by comparing sense and antisense of the
same tether. Tether, the nonmonomeric sequences in mouse L1 promoter, was not noted
as a critical regulator in promoter activity in the previous study. We found that tether
itself has limited activity. However, it can influence a monomers' activity as much as five
folds (Fig. 12). In the A_I subfamily, we compared the second monomer along with
monomer plus tether. It is interesting that the addition of a tether sequence decreased the
promoter activity by 80%. After adding the first monomer to the structure, the promoter
activity rebounded 25%. For TF subfamilies, we compared a few active different single
monomers with the plus tether accordingly. In all three different cases, we observed that
promoters could acquire extra activity in varying degrees. There might be a slight
difference in the activity between two different types of promoters. Still, previous
experiments (Fig. 7 to Fig. 10) indicate that all tethers cannot generate intense promoter
activity. Also, the dual-luciferase assay is an enzymatic luminescence assay measuring
the outcome of a combination between transcription and post-transcriptional processes.
Increasing or decreasing promoter activity could come from either transcription, posttranscription, or both. To be fully demonstrated, a further detailed study is required.
Despite the differences between any given cell lines, we have noticed the
consistency of the F type of promoter activity suppression in HeLa cells. One of the most
significant differences between A-type and F type is the YY1 binding site. It might be
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that YY1 has different roles in human and mouse cell lines. To be more specific, YY1
might be a suppressor in the human cell line and an activator in the mouse cell line.
However, the mechanism still needs to have more evidence and study to be better
understood.
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Chapter 3
Evaluating the retrotransposition potential from different mouse L1 subfamilies

Abstract
Long interspersed element type 1 (L1) sequences occupy almost 17% of the
human genome, and the majority of these L1s are inactive due to 5' truncation. Recently,
targeted or whole-genome sequencing has revealed abnormal L1 activities across
multiple cancer types. Animal models are critical for investigating L1 insertion events
and the associated consequences in vivo. We have previously used a highly active codonoptimized L1 element (ORFeus-Mm) as the transgene. However, there is a question about
whether the synthetic element works similarly as endogenous L1s work in vivo. To fully
capture the picture of L1 insertion events, we systematically evaluated the
retrotransposition potential of native L1 elements from the mouse genome. A streamlined
cloning method was established for screening by utilizing the dual-luciferase reporter
system. The firefly luciferase acts as the retrotransposition indicator, and Renilla
luciferase serves as a control. We have cloned numerous full-length L1 elements across
all potential active subfamilies from the mouse genome. By high-throughput dualluciferase assay, we can investigate current L1s activity and have a comprehensive
understanding of each subfamily. Also, the hyperactive endogenous L1 element will be
the transgene in further studies.

Introduction
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By applying next-generation sequencing, scientists have revealed that only 1.1%
of the human genome is occupied by exons, which can code proteins or peptides (Venter
et al., 2001). Unexpectedly, transposable elements constitute over 45% of the human
genome (Lander et al., 2001). Although these mobile elements comprise a considerable
percentage of the human genome, we have a limited understanding of them. Long
interspersed element-1 (L1 or LINE-1), the largest group of transposable elements in the
human genome, can induce endogenous insertional mutagenesis via a target primed
reverse transcription process (Hancks & Kazazian, 2016; Ostertag & Kazazian, 2001). L1
is the only family that remains active and has independent mobilities in the human
genome. L1s account for about 17% of the human genome and exist in ancestral genomes
even before mammalian evolutionary radiation.
According to human genome references, only a small portion (80~100 loci) of L1
families are still functional and can potentially generate insertions in individuals (Brouha
et al., 2003; Sassaman et al., 1997). Each individual may host additional active L1s (Beck
et al., 2010; E. C. Scott et al., 2016). To date, at least 30 cases of L1 insertion-induced
human diseases have been reported, and also include multiple cancer types (Hancks &
Kazazian, 2016). A few studies revealed L1 insertional mutagenesis could also initiate
colorectal cancer by following the classic two-hit pathway (Fearon, 2011; Kinzler &
Vogelstein, 1996; Miki et al., 1992; E. C. Scott et al., 2016). To have a better
comprehensive understanding of the L1 impact on human health, we propose that animal
models are critical to addressing this scientific question. Especially, mouse L1 is highly
similar to L1 of humans in many aspects, including structure (Fig. 1) and mechanism
(Feng et al., 1996; Martin, 2006).
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Figure 1. Scheme of typical full-length human and mouse L1 element. The yellow box
represents ORF1p coding sequences, and the blue box indicates the ORF2p coding
sequences.

They share some homology in other components except the distinct difference
between human and mouse L1 5'UTR (internal promoter). For ORF1p, a conserved and
high homology can be found in the C-terminus across many mammal species (including
humans and mice) (Martin, 2006). As we discussed in the previous chapter, the Nterminus shows relatively higher diversity across humans and mice (Holmes et al., 1992;
Martin & Bushman, 2001). Although all functions of ORF1p have not been revealed,
most studies have shown it serves as a nucleic acid-binding chaperone protein during L1
retrotransposition (Martin & Bushman, 2001; Martin et al., 2000). A pioneering study
also predicted the strong basic C-terminal property having the nucleic acid binding
potential (Loeb et al., 1986). Humans and mice share even higher homology in ORF2p,
around 63% of amino acid identity (Wagstaff, Barnerssoi, & Roy-Engel, 2011). Previous
studies already demonstrated the conserved three domains in both human and mouse L1
ORF2p (Fanning & Singer, 1987; Goodier et al., 2001; Mouse Genome Sequencing et al.,
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2002; Piskareva et al., 2013). Due to the high conservation between human and mouse,
profiling of mouse L1s activity would help develop a hyperactive endogenous L1
transgenic mouse model that can further be facilitated for L1 host regulation and
pathogenetic impact study.
Our lab used a codon-optimized mouse L1 (ORFeus-Mm) as a transgene to
construct mouse models (An et al., 2006). However, it is arguable whether the
engineered DNA sequence element has the same regulatory machinery as the
endogenous mouse L1. To adequately address the L1 insertion event, we proposed
systematically screening of endogenous mouse L1 elements to have a comprehensive
understanding of L1s activity across different subfamilies. Eventually, we aim to build a
new endogenous mouse model with the most active L1 element for L1 biology study and
pathological impact in vivo.

Materials and Methods
Backbone vector construction
There is a dual-SfiI clone site in front of firefly luciferase expression cassettes
(initially from pGL4.13, Promega, and heavily modified by our lab), which is flanked by
a 900-bp fragment of the human g-globin intron (Xie, Rosser, Thompson, Boeke, & An,
2011). pLK001 is derived from pWA304 by mutating the SfiI site in SV40 promoter
GGCCNNNNNGGCC to GGCCNNNNNTGCC amplified with WA0758
(TAGCTCAGAGGCAGAGGCGGCCTCG) and WA0759
(CGAGGCCGCCTCTGCCTCTGAGCTA). After point mutation is induced, the
additional SfiI enzyme site in the multiclonal site is not identical with the SfiI enzyme
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site on the pLK001. Plasmid pLK002 is generated by ligating pYX023 (after digestion
with NheI and BamHI) and pESD202 (after digestion with SpeI and BamHI). pLK003 is
created by ligating pLK001 (after digestion with BglII and EcoRV) and pLK003 (after
digestion with PmlI and BamHI). pLK003 is the backbone vector containing the dualluciferase cassette and two distinguished SfiI restriction sites for the high-throughput
cloning process.

Loci clone primer design
We used MacVector to design locus-specific PCR amplification primers. We
designed primers for first-round PCR based on flanking sequences of an L1 locus that are
at least 1000 bp away from both 5' and 3' ends. For the second-round PCR, we designed a
5' primer with ~ 100 bp space from the first nucleotide of L1 5'UTR, that covers the 5'
target site duplication sequences (TSDs). 3' primers do not cover all L1 3'UTR sequences.
In both 5' and 3' primer design, we always preferentially selected oligonucleotides
(oligos) with a minimal Tm of 60°C. Lastly, we added SfiI recognized sequences at both
ends of the L1 locus by PCR reactions for cloning convenience. Two unidentical SfiI
restriction sites (5’-AGGCCAAAATGGCC-3’ and 5’-TGGCCTGACAGGCC-3’) were
added to 5’UTR and 3’UTR primers, respectively.

Insertional fragment clone
For insertion fragments, we applied two-step PCR (Primestar and Nested PCR,
Table 1) for all L1 loci directly from C57BL/6J mouse genomic DNA with SfiI
overhanging oligos. All amplified fragments from the mouse genome were digested with
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SfiI restriction enzyme (NEB) overnight at 50°C. Products of digested reactions were
separated and inspected with 1% agarose gel electrophoresis. To minimize the UV lightinduced mutations, we used a Safer Imager 2.0 Blue Light Transilluminator (Invitrogen)
for the optimized clone process. Digested fragments were purified using the QIAquick
gel extraction kit (QIAGEN). Purified insertion fragments were ligated with a linear dualluciferase backbone vector via T4 DNA ligase (NEB) under room temperature (25 C) for
2 hours. After the ligation process, the reaction was heated to 65°C for 10 minutes, to
inactivate the T4 ligase. The reaction was chilled on ice for further steps.

Plasmid extraction and confirmation
Each newly cloned plasmid was transformed with E. coli Top 10 competent cells
by the classic heat shock method and then spread with beads on the LB agar plate
(containing carbenicillin); then incubated to form colonies. After overnight incubation,
we picked 2 to 3 colonies for further screening and cultured them in LB (Luria-Bertani
broth) medium for plasmid extraction (ZymoPURE plasmid Kits). Typically, we cultured
bacteria containing each plasmid in 5 ml LB broth medium overnight. To confirm
presence of each cloned plasmid, we used MacVector to predict product size after
restriction enzyme digestion. In addition, some of the clones were sequenced with Sanger
sequencing. The ultimate plan was to sequence all active full-length L1 elements.

Cell culture
HeLa cells were maintained at 37°C with a 5% CO2 incubator, and the humidity
was controlled continuously at 95%. For media, Dulbecco’s Modified Eagle’s Medium
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(DMEM) amended with 10% fetal bovine serum and 2 mM stable dipeptide of L-alanylL-glutamine was used.

L1 retrotransposition assay
For 24-well plate dual-luciferase assay experiments, we seeded 7 X 104 HeLa
cells in each well of a 24-well plate. We prepared and arrayed transfection complex to
each well after 24 hours following the instruction of Lipofectamine 3000 (Invitrogen).
Each well eventually received 500 ng plasmid mixed with 1 µl P3000 reagent, and 1.5 µl
Lipofectamine following the standard protocol of Lipofectamine 3000 Reagent
(Invitrogen). After a two-day transfection, we washed cells with 100 µl PBS and then
introduced them into fresh puromycin selective medium. For a large scale 96-well plate,
the high-throughput dual-luciferase assay was conducted by preparing 100 ng plasmid
per well transfection mixture buffered in reduced serum medium, which contained 0.3 µl
lipofectamine 3000 and 0.2 µl P3000. We arrayed 10 µl transfection complex in each
well of a 96-well plate. Then, a HeLa cell suspension was added to achieve a final density
of 2.5 104 cells per well in 100 µl medium (where the transfection complex is not
counted). After 48 hours of post-transfection, the medium was removed and puromycin
added to selective medium after washing the cells with 100 µl PBS. After four days of
selection, cells were harvested and the dual-luciferase signal was measured with a
luminometer (Promega).

Dual-luciferase luminescence measurement
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L1 retrotransposition assay was measured with the dual-luciferase reporter assay
system (Promega) based on manufacturer instructions. After washing with PBS buffer,
100 µl cell lysis buffer per well was used to harvest cells in 24-well plates. Accordingly,
20 µl cell lysis buffer per well was used for 96-well plates. In both manners, 20 µl cell
lysis suspension was transferred to 96-well luminescence reading plates, followed by 15
minutes cell lysis incubation. Sequential measurement of firefly luciferase and Renilla
luciferase was done by adding 100 µl Luciferase Assay Reagent II and 100 µl Stop & Glo
Reagent, respectively. Both readings were done with the GloMax Multi Detection System
(Promega).

Data normalization
Firefly luciferase was the reporter cassette to represent the activity of L1
retrotransposition. In contrast, Renilla luciferase was the internal control reporter with an
independent promoter from herpes simplex virus thymidine kinase (HSV-TK). We used
normalized data to fairly represent L1 retrotransposition activity by calculating the firefly
luciferase raw signal's value over the Renilla luciferase raw signal.

Primestar PCR protocol

1. The following components were combined into each designated tube/well:
Master Mix
•

11.6 ul

water

•

4 ul

5x PrimeStar Buffer

•

1.6 ul

dNTPs (2.5 mM)
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•

0.8 ul

PrimeStar DNA Polymerase

18 ul of Master Mix was added into each tube with the following:
•

0.5 ul

F1 Primer

•

0.5 ul

R1 Primer

•

1 ul

DNA (50ng/ul)

2. Cycling Conditions:
Using Mastercycler – PS60
Temperature

Time

98°C

2 minutes

98°C

10 seconds

60°C

15 seconds

68°C

5 minutes

4°

Hold

Cycle #

35cycles

Table 1. PCR cycles for full-length L1 cloning

Nested PCR protocol
1. Diluted first-round PCR 1:100 in molecular grade water
Combined the following components into each designated tube/well:
Master Mix
•

11.6 ul

water

•

4 ul

5x PrimeStar Buffer

•

1.6 ul

dNTPs (2.5 mM)
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•

0.8 ul

PrimeStar DNA Polymerase

18 ul of Master Mix was added into each tube with the following:
•

0.5 ul

F1 Primer

•

0.5 ul

R1 Primer

•

1 ul

Diluted 1st Round Product

2. Cycling Conditions: Same as the first-round PS60 in a Master Cycler

L1 retrotransposition assay workflow
Initially, we utilized the bioinformatics analysis to filter potentially active L1
elements in the mouse genome (also called ‘full-length L1’) with at least two monomers
in 5’UTR (details about how we selected L1s for this study are in the Results section).
After collecting individual locus information, we retrieved the sequences from the
genome browser (UCSC genome browser, University of California, Santa Cruz) and
designed two pairs of primers for each locus. The outer pair of primers were usually
targeted flanking sequences of individual L1 elements and a few hundred base pairs away
from the locus. The inner pair of primers were targeted upstream of the 5’ TSD site and
covered partial 3’UTR (Fig. 2A). The typical length of the L1 element was around 6 kb
in this study. By facilitating customized nonidentical SfiI sites in both the backbone
vector and L1 insertion fragment (details in Results section), we cloned L1 elements from
the mouse genome to the reporter vector in a high-throughput manner (Fig. 2B). Once
confirmed expected clones were obtained (details of confirmation in Results section), we
transfected the plasmid into HeLa cells and harvested cells for signal measurement. The
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assay also included antibiotic selection (puromycin) to only retain successfully
transfected cells and enrich the signal (Fig. 2C).

Figure 2. General workflow of L1 retrotransposition assay. (A) Two-step PCR to amplify
L1 locus directly from the mouse genome. (B) With the help of unique SfiI restriction
enzyme sites, L1 fragments cloned into dual-luciferase reporter vector. (C) In vitro assay
to evaluate L1 activity via transfection and selection process with HeLa cells.

Results
Dual-luciferase vector construction
To quantitatively evaluate the L1 retrotransposition activity, only limited methods
are available for L1 insertion frequency characterization. The first available method was
facilitated by antibiotic selection back in 1996 (Moran et al., 1996). They constructed an
intron disrupted neo gene as reporter cassette, which is a selectable marker. Only those
HeLa cells that are successfully transfected and generating de novo insertions can survive
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under G418 (an analog of neomycin sulfate) selection pressure. Although it was a
breakthrough method visually allowing assay of the L1 retrotransposition activity via
counting colonies, still the neo reporter method takes over 30 days of bench work. Within
the same group, they developed an updated version of reporter cassette by replacing neo
with an enhanced green fluorescence protein (EGFP) cassette (Ostertag, Prak,
DeBerardinis, Moran, & Kazazian, 2000). By applying fluorescence microscopy and
software analysis, they were able to test L1 retrotransposition in a 6-well plate within
seven days. As discussed previously, massive L1 copies in the mouse genome and
existing methods are unpractical for the high-throughput screening process. Hence, our
lab developed a dual-luciferase retrotransposition assay to test L1 retrotransposition
activity in vivo (Xie, Rosser, Thompson, Boeke, & An, 2011). For further convenience of
the high-throughput cloning process, we used two distinguished SfiI enzyme sites (5'GGCCNNNNNGGCC-3'), which can both be digested by SfiI (NEB). It can also ligate
with different complementary sequences (from both ends; insertion fragments) to ensure
the proper orientation of the cloned fragment.
pLK001, the source of firefly luciferase cassette in the dual-luciferase vector, has
a PCR-induced point mutation to disrupt the unwanted SfiI site (mutate from
GGCCNNNNNGGCC to GGCCNNNNNTGCC). We have also done sequencing to
confirm the point mutation was successfully induced, and two of eight clones were
confirmed by Sanger sequencing (Fig. 3). pLK002, which contains Renilla luciferase
cassette, was cloned simply by ligation fragments from pYX023 and pESD202 (described
in Methods).
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Figure 3. Sanger sequencing confirmation of successful point mutation (G>T) and
dysfunction of undesired SfiI restriction site

We applied the classic restriction enzyme cloning to generate a dual-luciferase
reporter vector via a combination of firefly luciferase (from pLK001) and Renilla
luciferase (from pLK002) cassettes cloning methods. Based on the predicted MacVector
map, we designed a restriction enzyme digest reaction with BgIII and EcoRV for
pLK001, and with BamHI and PmlI for pLK002 (Fig. 4A). Both BgIII and BamHI create
sticky ends that can form complementary sequences with each other after enzymatic
reactions (Fig. 4B). Besides, both EcoRV and PmlI will produce blunt ends. We used the
restriction enzyme to fabricate insertion fragments and backbones by digestion of both
pLK001 and pLK002. After purification with gel electrophoresis, we ligated expected
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fragments that previously came from pLK001 and pLK002 with T4 DNA ligase (NEB) to
form pLK003 (final dual-luciferase reporter vector).
To confirm if the expected pLK003 was successfully cloned, we used MacVector
to predict the map of pLK003. Based on predicted sequences, we chose PvuII (NEB) to
digest pLK003 and confirmed the construction using gel electrophoresis (Fig. 5A). The 9
kb plasmid pLK003 can be digested into five different sized DNA fragments ranging
from less than 500 bp up to almost 5000 bp with predicted enzymatic digest (Fig. 5B).
pLK001 and pLK002, two source plasmids of pLK003, can also be divided into three and
two different size fragments, respectively (Fig. 5C and 5D). We cloned the expected
dual-luciferase reporter vector for the L1 retrotransposition assay. Sanger sequencing also
was performed later on individual clones.

Figure 4. Dual-luciferase reporter vector construction. (A) Restriction digest from
pLK001 and pLK002 to create compatible sites for further ligation. (B) Sequences of
restriction site after digest.
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L1MdTfI-1728458

Forward primer

Reverse primer

First-round PCR

WA0695 (F1)

WA0696 (R1)

Second-round PCR

WA0860 (F2)

WA0861 (R2)

Table 2. Two-step PCR primers for the first L1 clone.

Figure 5. pLK003 confirmation with PvuII restriction digest. (A) Gel image to show the
digested fragments match the MacVector prediction. (B) MacVector PvuII prediction
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map of pLK003. (C) MacVector PvuII prediction map of pLK001. (D) MacVector PvuII
prediction map of pLK002.

L1 loci selection for assay
The latest whole-genome biostatistics analysis showed over 20,000 copies of L1s
having intact and potentially functional RT domains in the mouse genome (Sookdeo et
al., 2013). In a previous study, Goodier also believes that there are around 3000 fulllength L1 elements in the mouse genome in three large active families (A, TF, and GF)
that could be potentially active (Goodier et al., 2001). It would not be a practical option
to profile all possible active elements in the mouse genome. Simultaneously, nonhomology promoters across different subfamilies make more challenges for determining
activity across different subfamilies.
Although previous studies claimed 29 families were identified through the mouse
genome, only younger families have possible activity based on single lineage theory
(Adey et al., 1994; Sookdeo et al., 2013). We decided to focus on those seven youngest
families based on 5'UTR phylogenetic tree prediction (Fig. 6). The youngest subfamily is
A_I (only 0.21-million-year-old), which is supposed to be rapidly expanding into new
subfamilies. However, previous studies have never identified any hyperactive L1 element
from A subfamilies. Moreover, TF subfamilies were shown to have significantly higher
RNA expression than A-type L1s detected from two mouse cell lines (Naas et al., 1998).
In our study, we sought a comprehensive evaluation of L1 activity across different young
subfamilies to help understand why the new subfamilies did not have dominant
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expression yet in the mouse genome. To achieve the objectives, we developed a general
sampling method based on the assist of bioinformatic analysis (Sookdeo et al., 2013).

Figure 6. Mouse L1 subfamilies phylogenetic tree only shows a few youngest
subfamilies and their age in the host genome. This figure was redrawn based on
Sookdeo's work (Sookdeo et al., 2013). Two different colors indicate different types of
promoters.

106

Table 3. Potentially active full-length mouse L1 copy numbers across seven young
subfamilies classified by amino acid mutation. MutORF1+2 represents the amino acid
mutation number compared with consensus reference. In each subfamily, we have a
general rule of randomly selecting 10% of the total population as representatives for each
category. Highlighted colors also indicate different numbers of elements cloned in the
sampling process. In A_I, we have cloned six elements for four mutations, four elements
for five mutations and six mutations.

To be considered full-length L1 elements from the mouse genome, an individual
locus should be between 5000 bp to 8000 bp and have no ambiguous identity (both 5' and
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3' are from the same subfamily, and the whole element has not gone through
recombination). Due to the previous study having shown at least two monomers required
for mouse L1 promoter activity, we also set the two-monomer threshold for the sampling
process (DeBerardinis & Kazazian, 1999). Not only the promoter is critical for L1
retrotransposition activity; functional ORF1p and ORF2p are also necessary (Feng et al.,
1996; Holmes et al., 1992; Martin, 2006; Martin & Bushman, 2001; Martin et al., 2000;
Piskareva et al., 2013). Hence, we defined potential active mouse L1s with the same
length as their corresponding consensus sequences.
We mainly focused on L1 elements having less than ten amino acid mutations
(Table 3). For both A_III and Gf_II, we have not identified any element having less than
ten mutations. Especially in Gf_II, only eight elements have over a thousand amino acid
mutations, most likely due to their severe truncation. Under that circumstance, we did not
clone any element from Gf_II and only included one element from A_III. For those
eighty-four clones, we highlighted in the table and broadly covered all categories in the
aspect of amino acid mutations.

Clone L1 loci into dual-luciferase reporter vector
Since we have established the dual-luciferase reporter vector, we conducted
studies to evaluate L1 retrotransposition activity in vitro. To compare different L1 loci
across different subfamilies, we established a two-step PCR protocol (details in
Methods). We designed two pairs of primers for each locus, including the first successful
clone pLK004 (Table 2). The inner pair of primers has SfiI enzyme digest sequences in
both 5’ and 3’ sites that are not comparable to avoid self-ligation (Fig. 7A).
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The first successful cloned L1 locus comes from Tf_I subfamilies and is around 6 kb like
any other typical full-length L1 elements. As we previously discussed in Methods, we
gave extra flanking sequences spacer for first-round PCR with mouse genomic DNA
template to avoid non-specific amplicons. Due to massive repetitive copies of L1 in the
mouse genome that share high similarity, if we directly tried to amplify a specific locus,
it would be a considerable challenge for generating a homology amplicon library for
cloning. For the pLK004 clone (L1MdTfI-1728458), we designed WA0695 and WA0696
as first-round PCR primers, while WA0860 and WA0861 were used as second-round
PCR primers. We could amplify over 7000 bp and 6000 bp products as expected in each
step of PCR, respectively (Fig. 7A). The second step PCR amplified the slightly shorter
amplicon that used the PCR product from the previous step as a template. Both insertion
fragment (a product from second-round PCR) and backbone vector (pLK003) were
digested with SfiI overnight. We purified both reactions with the QIAquick purification
kit (Qiagen) and then did ligation with both fragments to remove the residue and trace.
After successfully cloning the cloning candidates for pLK004, we obtained restriction
digest predictions with AccI (NEB) through MacVector (Fig. 7B).
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Figure 7. Confirmation of the first successful L1 clone in the dual-luciferase vector. (A)
Gel image indicates the product of the first-round and second-round PCR, respectively.
First-round PCR uses C57BL/6J mouse genomic DNA as a template, while the PCR
product in the previous step is templated for second-round PCR. Highlight part of primers
is the SfiI restriction digest site added on both ends of each L1 element for cloning
convenience. (B) MacVector plasmid map (pLK004) of L1MdTfI-1728458 L1 locus in
dual-luciferase vector. Also, predict the fragments of the AccI restriction enzyme digest
the pLK004 plasmid. (C) Gel image to confirm the AccI digested pLK004 (screened five
colonies of the same locus) matching the predicted map.
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Figure 8. Sanger sequencing for locus confirmation. (A) Sequencing primer design
example with pCH022 plasmid. The average distance between each primer is around 650
bp to have precise overlap with each neighbor primer, and we cover both 3’ and 5’
junctions. (B) A summary table of all sequencing results has been done. Numbers in
parentheses indicate the confirmed nucleic acid mutation over the references.

The gel image confirmed that we obtained a few clones matching the prediction
(Fig. 7C). We also designed primers for Sanger sequencing to further validate some
clones' correction. We sequenced over 79,000 bp with a low mismatch rate of around
0.01% (Fig. 8A). Half of the sequenced clones did not have any mutations, while most of
the remaining clones had one mutation compared to their consensus (Fig. 8B). Still, it is
debatable if those mutations come from PCR-induced mismatches or the genomic
template.
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L1 retrotransposition assay optimization
Our lab tried to establish a dual-luciferase assay (Xie, Rosser, Thompson, Boeke,
& An, 2011) with a few control samples in a previous study. We expected to optimize
work schemes from the previous study and massively screen L1 elements from the mouse
genome. To minimize all potential factors and challenges of this assay, we started with a
24-well plate format instead of a 96-well plate. We always included a positive control
plasmid (pYX014) that comes from a hyperactive human L1 (L1-rp) for optimization
purposes. Transfection duration could be a significant factor in influencing transfection
efficiency and final luciferase signal yield. Hence, we used FuGENE HD (Promega) to
compare 24-hour transfection with a 48-hour transfection. It was evident there was a
dramatic signal boost with longer transfection incubation time (Fig. 9A). Besides, we
noticed that the fresh-thawed cell line had a slightly higher standard deviation than the
cell line that already had been passed a few times (Fig. 9B).
We found increasing transfection incubation can help increase the transfection
efficiency and eventually increase the firefly luciferase signal. We preferred to have twoday transfection instead of a standard one-day transfection, which potentially will
generate broader dynamics for the assay. Besides, antibiotic (puromycin in our vector)
selection could be another critical factor in the luciferase reporter assay. The standard
protocol used trypsinization before the selection, which could induce more deviation and
some signal loss. Especially when adhesive cells were trypsinized and detached, cells
would be more sensitive and fragile to selection pressure. We compared direct selection
(without trypsinization) with trypsinization selection (previous protocol). Not
surprisingly, we found direct selection had a better signal enrichment (Fig. 9C).
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However, the firefly luciferase signal still was not enough for the conventional assay
dynamic range. We therefore initiated work to evaluate the transfection efficiency by
using a similar size plasmid with a visible fluorescence GFP reporter (pCEP-PuroEGFP), which can be monitored through the same workflow dual-luciferase plasmids.
After a comparison across three different transfection reagents, we concluded that
Lipofectamine 3000 had the best transfection efficiency. Based on the instruction
protocol for Lipofectamine 3000, we optimized the ratio between plasmid and
transfection reagents following the manufacturer’s manual's guideline. Fluorescence
microscopy showed that 1.5 ul lipofectamine 3000 per well had a better transfection
efficiency than 0.75 ul (Fig. 9D).
To achieve a better dynamic range, which would provide high resolution in actual
L1 elements evaluation, we carried on optimizing Lipofectamine 3000 and other factors.
We tried using two different seeding densities (9 × 104/well and 6.5 × 104/well) based on
previous protocol and followed two-day transfection with three-day selection (Fig. 10A).
Ideally, we expected to achieve over a hundred-fold range from positive control over the
background. We scaled up the experiment from using 24-well plates to using 96-well
plates and included two different seeding densities (1.4 × 104/well and 1.2 × 104/well) for
a high-throughput manner (Fig. 10B). In both assays, we achieved a modest amount of
signal. We also noticed different batches of plasmid preps could affect the stability and
consistency of the dual-luciferase assay (Fig. 10C). To address the concern, we freshly
prepared all plasmids in the same batch.
The reverse transfection method had a few advantages over the standard protocol.
In the standard protocol, we usually started with counting and seeding cells. After 24-
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hour incubation, the transfection complex was added into each well and mixed by gently
shaking plates. In contrast, we added the transfection complex into each well first and
then added proper cell suspension into corresponding wells. We were able to shorten the
reverse transfection method by one day. Besides, reverse transfection eliminated a few
steps, including extra handling and causing a significant standard deviation. We tried to
compare transfection methods to confirm if reverse transfection helps to lower SD and
variation (Fig. 10D). Indeed, the result indicated that reverse transfection can be helpful
and efficient for high-throughput dual-luciferase assay.

Standard

Longer

Direct
selection

Trypsinization

Old

1.5 ul Lipofectamine 3000 per well

New

0.75 ul Lipofectamine 3000 per well

Figure 9. Firefly luciferase data in 24-well plate platform. (A) Compared standard 24
hours transfection and 48 hours transfection. The following selection days and strength
are the same, and each group had four biological replicates. (B) Compared 20 passes
HeLa cells and fresh thawed HeLa cells in firefly luciferase expression level. (C)

114
Compared Puromycin selection methods. The direct selection represents a direct
changing medium with puromycin medium, while trypsinization indicates trypsinizing
cells and reseed 50% of them in a new well with puro medium. (D) According to the
manufacturer’s manual, start to use higher-efficiency transfection reagents
(Lipofectamine 3000) and optimize the transfection condition.

For the transfection complex, it is worth noting that plasmid concentration can
potentially influence the lipid complex-forming step, which further can affect transfection
efficiency. We decided to test the potential effect of plasmid concentration (200 ng/µl
and 500 ng/µl) for transfection complex preparation (Fig. 11A). As the data suggest, less
plasmid concentration was not causing much change for the firefly luciferase signal. It
was always a technical challenge to achieve over 500 ng/µl in every single plasmid
preparation. However, the data prove that lower concentration would not hurt much in the
accuracy of the assay. With three different seeding densities, we also observed that higher
seeding density favored firefly luciferase, which helped us finalize seeding density in the
range between 1.8 × 104 and 2.6 × 104 per well (Fig. 11B). We did not notice any
significant difference by comparing two different endotoxin-free plasmid purification
kits, and decided to use a more cost-efficient one for future experiments (Fig. 11C). A
four-day selection clearly showed a better and distinct separation between two control
plasmids (Fig. 11D). This better dynamic range would benefit our assay in comparison
across many different L1 loci.
We finalized the protocol for dual-luciferase assay in the 96-well format. We used
a GFP control plasmid (pCEP-Puro-EGFP) to optimize transfection efficiency and
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expression. High GFP signal was achieved in 0.3 µl lipofectamine 3000 group with 2.5
µg/ml puromycin selection (Fig. 12A-D). The final HeLa cell transfection complex
included 100 ng plasmid, 0.3 µl lipofectamine 3000, and 0.2 µl P3000 per well. To enrich
the signal for better measurement dynamic range, we also included 4-day selection with
2.5 µg/ml puromycin after 2-day transfection incubation (Fig. 12E). On day seven, cells
would be lysed and measured for enzymatic activity with the Dual-Luciferase Reporter
Assay System (Promega).

pYX14

pLK006
Batch 1

pYX14

pLK006
Batch 2

pYX14

pLK006
Standard

pYX14

pLK006
Reverse

Figure 10. Firefly luciferase data with lipofectamine 3000 transfections. (A) Comparison
of different seeding densities with standard transfection method in 24-well plate. (B)
Scale-up experiment to 96-well plate and compare two different seeding densities. (C)
Comparison of two batches of the same plasmids with the same protocol. (D) Test two
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different transfection methods (standard and reverse transfection) for lower standard
deviation.

pYX14 pLK006 pCH017 pCH018 pCH017 pCH018
Midi-prep

Zymo

pYX14

pLK006

3 day selection

pYX14

4 day selection

Figure 11. Firefly luciferase raw data with lipofectamine 3000 transfection in 96-well
plate. (A) Comparison of different plasmid concentrations for transfection complex
preparation. (B) The seeding densities can influence the firefly luciferase. (C)
Comparison of two mini prep kits of the same plasmids with the same protocol. (D) Test
longer selection duration with standard protocol.

pLK006
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Figure 12. L1 retrotransposition cell assay workflow. (A) Test transfection efficiency
with 0.3 µl Lipofectamine per well. (B) Test transfection efficiency with 0.15 µl
Lipofectamine per well. (C) Transfection efficiency without puromycin selection. (D)
Transfection efficiency with 2.5 µg/ml puromycin selection

Mouse L1 retrotransposition across young subfamilies
A_I subfamily, a young mouse L1 subfamily, is only 0.21 million years old
(Sookdeo et al., 2013). Interestingly, most previous studies have found active
pathogenetic TF elements and some GF elements (Goodier et al., 2001; Naas et al., 1998).
Also, only a limited number of L1 elements from the A subfamily were tested. Those
elements appeared not to have as much activity as other subfamilies (TF and GF) in
Goodier’s in vitro assays. However, in our bioinformatics analysis, the A_I subfamily
showed a massive number of elements that only have a few amino acid mutations
compared with their consensus sequences (Table 3).
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Moreover, A_I has the most intact L1 elements distribution profile. L1 copies can
be found from the 'zero mutation' category (amino acid sequences match the consensus)
to over 'one thousand mutations' (heavily truncated). The total copy number of L1
elements is over five hundred, which is also the most abundant across eight families in
our analysis. Hence, we have cloned and tested twenty-eight loci from the A_I subfamily
(more clones from A_I than other subfamilies). Each locus has two individual clones in
our assay to assure the accuracy (Fig. 13). Each clone was measured with both firefly
luciferase and Renilla luciferase. After calculating the normalized activity using firefly
luciferase value over Renilla luciferase value, the activity value was further normalized to
L1rp (a hyperactive human L1 element shown to have relatively high activity in many
different studies) as a final activity value. Unsurprisingly, the pCH017, which has no
amino acid mutation compared with consensus sequences, was shown to have the most
activity in the A_I subfamily.
It is worth noting that pCH018 has only one amino acid mutation compared with
consensus. It has insignificant retrotransposition activity (due to high SD in this specific
data, we had repeated experiments later to study and confirm pCH018 having little
activity). As the previous discussion in the Introduction, ORF1p has a coiled-coil domain
in the N-terminal region which is critical for forming a trimer complex for L1
retrotransposition activity (Khazina et al., 2011; Martin, 2006; Martin et al., 2003; Martin
& Bushman, 2001; Martin et al., 2000). L1 retrotransposition does not solely rely on the
function of ORF1p. Still, as a chaperone protein, its dysfunction would have a high
impact on L1 retrotransposition activity. Especially as a promoter of pCH018 having
above-average activity, we assumed that this point mutation from glutamic acid to lysine
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(location is 111 of ORF1p consensus) in the coiled-coil domain of ORF1 might play a
critical role (Fig. 14A). At the same time, further study and validation are required to
reach a definite conclusion.

Figure 13. L1 retrotransposition assay to profile selective elements from A_I subfamily.
Each locus has two to three individual clones, and two clones were assayed in this study.
'#Mut' indicates the mutation numbers (amino acid) of each locus, comparing the
consensus sequences.
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Figure 14. Amino acid sequence alignment of ORF1p and ORF2p (A_I consensus,
pCH018, and pCH019). (A) The only amino acid mutation in ORF1 of pCH018. (B) One
of two amino acid mutations in ORF2 of pCH019. (C) The other mutation in ORF2 of
pCH019.

pCH019, only having two amino acid mutations, also showed little activity in our
assay, and its promoter had a fair amount of transcriptional activity (in later tests).
Although one of the two-point mutations was located in a non-domain region, the other
was in the reverse transcriptase (RT) domain. RT domain has demonstrated its
importance in the L1 insertion process (Kulpa & Moran, 2006; Mathias et al., 1991).
Proline (P) is commonly found in secondary structure (turns), and arginine (R) has an
opposite property, tending to interact with polar environments. It might be this mutation
at 498 of ORF2p that altered the confirmation and caused dysfunction of RT. Eventually,
insignificant retrotransposition was detected with pCH019.
Similarly, further experiments and validation are required for better
understanding. Increasing the number of mutations makes it harder and harder to capture
active L1 elements with more amino acid mutations. Surprisingly, two elements have
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unexpected retrotransposition activity, even with six or seven amino acid mutations (Fig.
13). It might be interesting to have a further investigation of those two elements, to help
us understand how L1 can evolve to give rise to new subfamilies once in a while in the
evolutionary process.
Besides the A_I subfamily, we also included the other two A-type subfamilies.
A_II and A_III have been part of the mouse genome for around 1.6 and 2.1 million years,
respectively (Fig. 6). We could not identify any elements with less than four amino acid
mutations in both subfamilies compared with their consensus sequences. Moreover, we
only were able to identify two individual L1 elements having less than fifty mutations
and more than twenty mutations (Fig. 6). Indeed, we included a L1 element with thirty
amino acid mutations from that category, and the retrotransposition activity was
insignificant, which is expected based on observation in the A_I subfamily (Fig. 15). In
all seven loci from A_II, we did not capture any single element having a promising
activity even with the least mutations in the family (Fig. 15).
The 0.75 million years old GF_I subfamily is about the median age among those
seven subfamilies. In the previous bioinformatic analysis, we found only thirty-six
elements that can be recognized as potential active L1 elements in our definition (Table
3). Moreover, seventeen of GF_I in our candidate pool have more than fifty amino acid
mutations than consensus sequences. In our assay, we only found pCH010 that has the
lowest mutation number showed hyperactivity, while three other L1 elements from GF_I
also showed some debatable activity. Overall, we have not observed much activity.
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Figure 15. L1 retrotransposition assay to profile selective elements from GF_I subfamily.
Each locus has two to three individual clones, and two clones were assayed in this study.
'#Mut' indicates the mutation numbers (amino acid) of each locus, comparing the
consensus sequences.
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Figure 16. L1 retrotransposition assay to profile selective elements from A_II and A_III
subfamilies. Each locus has two to three individual clones, and two clones were assayed
in this study. '#Mut' indicates the mutation numbers (amino acid) of each locus,
comparing the consensus sequences.

L1 elements from GF_I acted as we expected. A previous study showed that many
L1 elements from GF_I have excellent retrotransposition activity (Goodier et al., 2001).
However, it is worth noting that besides the different assay used in their study, they also
added an additional human cytomegalovirus (CMV) promoter in front of most L1
elements they tested.
TF subfamilies have been reported as one of the active groups in many previous
studies. Two pathogenetic TF elements (L1orl and L1spa) were found from mouse models
and caused disease phenotypes (Kingsmore et al., 1994; Kohrman et al., 1996). L1spa and
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L1orl, two insertional mutagens, happened to cause spastic and Orleans reeler mouse
phenotypes, respectively (Kingsmore et al., 1994; Kohrman et al., 1996). Moreover, both
of the insertions were still shown to have intact L1 sequences and functionality that
potentially remain active for further mobility (Kingsmore et al., 1994; Kohrman et al.,
1996; Takahara et al., 1996). The sequence similarity between these two elements was
further studied and classified as a novel subfamily called TF (Naas et al., 1998). The same
study found the TF family having a much higher RNA expression level than other
families (Naas et al., 1998). Another in vivo study done recently by the Faulkner group
found that a few heritable L1 TF elements conducted germline insertions (Richardson et
al., 2017).
As many pieces of evidence and studies have shown, TF elements remain active in
the mouse genome. We investigated three young TF subfamilies to have a comprehensive
understanding of their activity. TF_I has a similar age with A_I, which is around 0.25
million years old. However, we could not identify any L1 elements from TF that have the
same amino acid sequences with consensus (Table 3). The twenty-six clones (thirteen
loci) we have assayed showed expected activity (Fig. 17). Since we have not sequenced
those elements with only one or two amino acid mutations in the TF_I subfamily, it is
worth noting that pMJ023/026 would be worth sequencing in full length to identify the
amino acid mutation which is most likely to play an essential role in retrotransposition
activity.
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Figure 17. L1 retrotransposition assay to profile selective elements from TF_I subfamily.
Each locus has two to three individual clones, and two clones were assayed in this study.
'#Mut' indicates the mutation numbers (amino acid) of each locus, comparing the
consensus sequences.

TF_II shows high similarity with TF_I with slight diversity from the phylogenetic
tree (Fig. 6). Moreover, both subfamilies have many elements across different amino acid
mutation categories that could be beneficial for studying the functionality impact of those
mutations (Table 3). Those similarities most likely come from a similar time span. TF_II
is around 0.27 million years old, which is just 0.2 million years older than TF_I and the
third youngest subfamily across the panel. Interestingly, most elements from TF_II tended
to be active in our assays, although most of them are just having an activity above the
background (Fig. 18).
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TF_III, the oldest subfamilies in the TF group, have almost 1.23 million years of
history. Despite the similar age between TF_III and A_II, TF_III shows a very similar
distribution pattern in the L1 elements count (Table 3). Not surprisingly, it has limited L1
retrotransposition activity across those elements (Fig. 19).

Figure 18. L1 retrotransposition assay to profile selective elements from TF_II
subfamily. Each locus has two to three individual clones, and two clones were assayed in
this study. '#Mut' indicates the mutation numbers (amino acid) of each locus, comparing
the consensus sequences.
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Figure 19. L1 retrotransposition assay to profile selective elements from TF_III
subfamily. Each locus has two to three individual clones, and two clones were assayed in
this study. '#Mut' indicates the mutation numbers (amino acid) of each locus, comparing
the consensus sequences.
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Figure 20. L1 retrotransposition assay to repeat active elements (> 5% activity of L1rp)
from previous screening. Each locus has two to three individual clones, and two clones
were assayed in this study.

To highlight and further confirm those active L1 elements in the mouse genome,
we have repeated the L1 retrotransposition assay at two different time points (Fig. 20).
We set the threshold for any element over 5% of L1rp, which is the standard in our assays
(mentioned in the previous section, which is an active human pathological element). Both
repeats were shown to have quite a consistency with previous screen data.
Overall, we can find the L1 retrotransposition activity profile across those three
groups (TF, GF, and A) is consistent with previous discoveries. TF tended to have more
active elements to show some extent of L1 retrotransposition activity based on the
median activity of L1 (Fig. 21). Besides, we observed an intuitive correlation between
age and L1 retrotransposition activity within TF_I, TF_II, and TF_III. The younger
subfamily has higher average activity, as well as median activity (Fig. 21). A_I, the
youngest subfamily in this study, showed the highest average activity with a relatively
low median, indicating that A_I has several exceptional active outliers (Fig. 13). Within
the three oldest subfamilies in our study, GF_I has a relatively higher average and median
activity than the other two, although it is the oldest of the three. It is worth noting that the
new emerging and young subfamilies tend to have a broad spectrum of activity, while
older subfamilies show little retrotransposition activity (Fig. 21).
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Figure 21. Box plot for all loci retrotransposition activity across seven subfamilies in our
study. The red cross indicates the mean activity of each subfamily. The Red line inside
each box represents where the median activity in the population. Outliers are outside the
box and marked as red dots.

Discussion
This chapter's objective is to profile and have a comprehensive understanding of
the current status of L1 elements in the mouse genome. We could also find some
hyperactive L1 elements that can be used as an endogenous transgene for further novel
mouse model generation. Pioneering studies have demonstrated three potential active
mouse L1 groups, including TF, GF, and A (An et al., 2006; Naas et al., 1998; Shehee et
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al., 1987; Yajima et al., 1999). Two different pathological active L1 elements were found
from the TF family in mouse models (Kingsmore et al., 1994; Naas et al., 1998; Takahara
et al., 1996). Moreover, the recent discovery of a series of germline inserted L1 elements
from the mouse model were all from TF subfamilies (Richardson et al., 2017). Although
several scattered elements were cloned and tested in different assays to compare different
mouse L1 retrotransposition activity, a comprehensive and systematic evaluation of
different L1 subfamilies is urged for a broader scope and understanding of active mouse
elements. Profiling different L1 subfamilies in the mouse genome will help understanding
of activity differences across young L1 subfamilies in the mouse genome, and establish a
pathogenic L1 model for human health study.
This chapter has profiled recently emerged and young subfamilies, which include
A_I, A_II, A_III, GF_I, TF_I, TF_II, and TF_III. Although we only cloned one element
from A_III, it still validates our hypothesis that no significant activity remains from those
old subfamilies. Ideally, we would clone every individual element from each subfamily
and have a comprehensive understanding of their activities. However, with over one
thousand L1 fragments, cloning is not practical for our goals. With the help of
bioinformatics analysis, we narrowed our focus down to those elements having fewer
amino acid mutations, that are more likely to be active. Still, the vast collection of mouse
L1 elements was challenging to work with in previous assays. We designed an approach
that covers a different number of mutation elements and includes more clones based on
the distribution of those L1 elements in the amino acid mutation summary table (Table
3).
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Technically, we established L1 retrotransposition assays with a high throughput
cloning approach by utilizing two SfiI restriction enzyme sites (unidentified DNA
sequences) on both PCR amplified fragments and backbone vectors. This technical
contribution makes extensive scale screening possible and provides convenience in the
cloning process. We have cloned over eighty individual elements from the black 6 mouse
genome.
In HeLa cells, we found the more amino acid mutations an L1 element has the
less likely it remains active. We also observed that elements having over five amino acid
mutations were less likely to remain active in our assay. It is worth noting that we found
that pCH017, an L1 element from the A_I subfamily, is the most active element across all
clones and even far more active than L1rp in our assays (Fig. 20). We also found a
hyperactive L1 element from GF, which can match up to 100% of L1rp's activity (Fig.
20). Interestingly, we could not find any L1 elements from TF subfamilies that show
similar activity with L1rp. It is unclear why our discovery is not consistent with previous
reports that TF families are active both in vitro and in vivo.
Lastly, the unexpected L1 retrotransposition activity across different young
subfamilies stimulates our interest in investigating the inconsistency with other studies. It
is worth noting that, although many studies and in vitro assays in the L1 field were done
by using HeLa cells, there is an apparent difference between mouse and human cells. A
previous study also showed that 5'UTR had distinguished A, GF, and TF families
(Goodier et al., 2001). Those distinct patterns in each monomeric structure of 5'UTR
showed a correlation between length and transcriptional activity (DeBerardinis &
Kazazian, 1999). Earlier in vitro assays also revealed that removing 5'UTR would
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entirely abolish the L1 retrotransposition activity (Naas et al., 1998). To further
investigate the L1 retrotransposition activity profile across young subfamilies, we
initiated study of L1 promoters in the mouse genome.
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Chapter 4
Discussion and future directions

With novel high throughput dual-luciferase cell assays, we characterized and
profiled a broad set of L1 retrotransposition and promoter activity from the mouse
genome. Our study results raised questions of why TF was shown to have surprisingly
high retrotransposition activity in vivo and was inconsistent with HeLa cell data. It could
be a meaningful for human and mouse L1 biology study that a promoter is not the only
determinant for L1 retrotransposition, but its promoter activity is critical for
retrotransposition activity.
Although we unexpectedly found a few hyperactive A_I elements showing
historically high activity in HeLa cells, further validation in other cell lines is needed.
Especially validation in mouse cell lines is necessary and meaningful to document if the
cellular environment supports mouse L1 transcription and retrotransposition activity. We
found more active L1 elements from the older subfamily TF_II over its younger sibling
(TF_I), which indicates there might be emerging a new dominant lineage of subfamilies.
Broader profiles and analyses are required to have a comprehensive understanding of the
L1 evolutionary process.
It is worth noting that we could not find a significant correlation between the L1
promoter and L1 retrotransposition activity. As L1 life cycle starting with transcription
initiated by the internal promoter from 5'UTR, we hypothesized that promoter activity
should follow some extent of correlation with L1 retrotransposition activity. Surprisingly,
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even with limited promoter activity, TF subfamilies still showed adequate insertion
capability in our cell assays.
To further investigate which component of L1 plays the most critical role for L1
retrotransposition, it would be meaningful to establish a chimeric series structure and test
the contribution of each part of the L1. With the amount of profiled L1 elements in our
study, we have found a few hyperactive mouse endogenous L1 elements across four
different young subfamilies. To test active L1 elements from the young subfamily in vivo,
especially in the mouse model, will allow us to monitor the activity profile across
different tissues and help capture the life path of the L1 insertion event. The work
documented here is the first comprehensive profiling and study of L1 activity across
young subfamilies in the mouse genome, providing significant contributions to the L1
field. Our work would promote answering fundamental L1 biology questions by
providing a transgenic mouse model.
By subcloning promoters directly from full-length L1 elements, we were able to
study promoter activity in general, confirming and expending the conclusion that length
corresponds to L1 activity and 2-monomer promoter is a minimum requirement. Our
study further expanded the understanding of the standard incomplete monomer on 5'end
that could significantly suppress or inspire promoter activity depending on its length. We
also validated that 2-monomer promoters are far more active than 1-monomer promoters
with their consensus sequences across all three young subfamilies.
In any given L1 promoters, their numerous factors would be worth considering.
We included upstream flanking sequences, tether, incomplete monomer, and length of the
promoter. We significantly contributed to the field to allow a better understanding of L1
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promoter activities. Our study has revealed that the single monomer solely can be
exceptionally active. Further study of how L1 promoter transcription factors can
influence L1 transcription level would strongly benefit the understanding of endogenous
L1 expression pattern and expression timing.

